Metal complexes
Dinuclear and trinuclear iridium/platinum complexes with multilegged ligands address the inefficiencies of existing triplet emitters in OLEDs by offering reduced luminescence lifetimes and enhanced infrared emissions, improving device performance and sensor capabilities.
Patent Information
- Application Number
- JP2020550749
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-03-19
- Filing Date
- 2019-03-18
- Publication Date
- 2024-11-13
- Estimated Expiration
- 2039-03-18
AI Technical Summary
Existing triplet emitters in phosphorescent organic electroluminescent devices (OLEDs) have long luminescence lifetimes, low photoluminescence quantum yields, and inefficient red emission, necessitating improvements for high brightness and low roll-off characteristics, particularly in infrared and deep red emission for applications like fingerprint and iris sensors.
Development of dinuclear, trinuclear, and tetranuclear iridium/platinum complexes with multilegged ligands that exhibit improved photophysical properties, including reduced luminescence lifetimes, enhanced quantum yields, and polarized emissions in the deep red or infrared region.
The new complexes provide shorter luminescence lifetimes, improved efficiency, and polarized emissions, enhancing the performance of OLEDs and sensors, particularly in the infrared region, suitable for applications such as infrared iris sensors.
Smart Images

Figure 0007582865000001 
Figure 0007582865000002 
Figure 0007582865000003
Abstract
Description
Detailed Description of the Invention
[0001] The present invention relates to metal complexes suitable for use as emitters in organic electroluminescent devices and as organic sensors.
[0002] According to the prior art, triplet emitters used in phosphorescent organic electroluminescent devices (OLEDs) are in particular bis- and tris-ortho-metallated iridium and bis-ortho-metallated platinum complexes with aromatic ligands, which are bonded to the metal via a negatively charged carbon atom and an uncharged nitrogen atom or via a negatively charged carbon atom and an uncharged carbene carbon atom. Examples of such complexes are tris(phenylpyridyl)iridium(III) and its derivatives, where the ligands used are, for example, 1- or 3-phenylisoquinone, 2-phenylquinoline or phenylcarbene. In this case, the iridium complexes generally have a fairly long emission lifetime, well above 1 μs. However, for use in OLEDs, a short emission lifetime is required to enable the operation of the OLED with high brightness and low roll-off characteristics. There is also still room for improvement in efficiency, especially of red-emitting phosphorescent emitters. Low triplet levels T in conventional red phosphorescent emitters 1 As a result, the photoluminescence quantum yield is well below the theoretically possible value, which is due to the low T 1 In this case, non-radiative channels play a large role, especially when the complexes have a high luminescence lifetime. Improvement by increasing the illumination level is desired here, which can also be achieved by reducing the photoluminescence lifetime.
[0003] The improvement of the stability of iridium complexes has been achieved by using polypodal ligands, as described, for example, in WO2016 / 124304. In the case of platinum complexes, it can be achieved by using tetradentate ligands, as described, for example, in WO2005 / 042550. Depending on the ligand structure, these complexes show red, orange, yellow, green or blue emission. Even in the case of complexes with polypodal or tetradentate ligands, there is still room for improvement in terms of the properties for use in organic electroluminescent devices, especially in terms of excited state luminescence lifetime and / or efficiency, but also voltage and / or lifetime.
[0004] A technical problem that has not yet been fully solved is to provide organic or organometallic compounds that emit efficiently in the infrared region of the spectrum, and further improvements are desired, also in the case of deep red emitting compounds. In particular, compounds that emit in the infrared region of the spectrum are interesting for use in sensors, such as fingerprint sensors and iris sensors. In an IR iris sensor, IR light is directed at the eye and the characteristic pattern of the IR light reflected by the eye is detected by an IR camera. The light source for this purpose may be an organic electroluminescent element that emits in the infrared region of the spectrum, and the provision of infrared emission is required for this purpose.
[0005] The problem addressed by the present invention is therefore to provide novel metal complexes suitable as emitters for use in OLEDs and sensors. A particular objective is to provide emitters that exhibit improved properties in terms of luminescence lifetime, efficiency, operating voltage and / or lifetime. A further problem addressed is to provide emitters that emit in the deep red or infrared region of the spectrum.
[0006] Surprisingly, it has been found that the di-, tri- and tetranuclear iridium / platinum complexes described below exhibit improved photophysical properties compared to the corresponding mononuclear complexes, and therefore result in improved properties when used in organic electroluminescent devices. More particularly, the compounds of the present invention have improved photoluminescence quantum yields and significantly reduced luminescence lifetimes. The shorter emission lifetimes result in improved roll-off characteristics of organic electroluminescent devices. Furthermore, the complexes exhibit polarized emission, and their emission is improved in efficiency. Furthermore, these complexes emit in the deep red or infrared region of the spectrum, and complexes showing particularly efficient infrared emission can also be obtained. The present invention provides these complexes and organic electroluminescent devices and sensors comprising these complexes.
[0007] The present invention provides a compound of formula (1): [ka] where the symbols and subscripts used are as follows: D is the same or different at each occurrence and is C or N; X is identical or different at each occurrence and is CR or N; L 1 , L 2 is the same or different at each occurrence and is a bidentate ancillary ligand; V 1 The central subligands are connected to each other and to L depending on the selection of n. 1 is a trivalent group bonded to V 2 is a divalent radical or a central ancillary ligand and L 2 are single bonds that connect the n is 1, 2 or 3; m is the same or different for each occurrence and is 0 or 1, where m=1 corresponds to V 2the atom to which the group is attached, X, is C, with the proviso that for each platinum subcomplex, at least one m is 1; R is the same or different at each occurrence and is H, D, F, Cl, Br, I, N(R 1 ) 2 , CN, NO 2 , OR 1 , S.R. 1 , COOR 1 , C(=O)N(R 1 ) 2 , Si(R 1 ) 3 , B(OR 1 ) 2 , C(=O)R 1 , P(=O)(R 1 ) 2 , S(=O)R 1 , S(=O) 2 R 1 , O.S.O. 2 R 1 , a linear alkyl group having 1 to 20 carbon atoms, or an alkenyl or alkynyl group having 2 to 20 carbon atoms, or a branched or cyclic alkyl group having 3 to 20 carbon atoms, where the alkyl, alkenyl or alkynyl group is in each case one or more R 1 radical, wherein one or more non-adjacent CH 2 The group is Si(R 1 ) 2 , C=O, NR 1 , O, S or CONR 1 or having 5 to 40 aromatic ring atoms, in each case having one or more R 1 an aromatic or heteroaromatic ring system, optionally substituted by a radical; at the same time, two R radicals may together form a ring system; R 1 are the same or different for each occurrence and are H, D, F, Cl, Br, I, N(R 2 ) 2 , CN, NO 2 , OR 2 , S.R. 2 , Si(R 2 )3 , B(OR 2 ) 2 , COOR 2 , C(=O)R 2 , P(=O)(R 2 ) 2 , S(=O)R 2 , S(=O) 2 R 2 , O.S.O. 2 R 2 , a linear alkyl group having 1 to 20 carbon atoms, or an alkenyl or alkynyl group having 2 to 20 carbon atoms, or a branched or cyclic alkyl group having 3 to 20 carbon atoms, where the alkyl, alkenyl or alkynyl group is in each case one or more R 2 radical, wherein one or more non-adjacent CH 2 The group is Si(R 2 ) 2 , C=O, NR 2 , O, S or CONR 2 or having 5 to 40 aromatic ring atoms, in each case having one or more R 2 an aromatic or heteroaromatic ring system, optionally substituted by a radical; 1 the radicals together may form a ring system; R 2 is identical or different at each occurrence and is H, D, F or an aliphatic, aromatic or heteroaromatic organic radical having 1 to 20 carbon atoms, in particular a hydrocarbyl radical (wherein one or more hydrogen atoms may be replaced by F).
[0008] Two R's or R's 1When radicals together form a ring system, it may be monocyclic or polycyclic and aliphatic, heteroaliphatic, aromatic or heteroaromatic. In this case, the radicals together forming the ring system may be adjacent, i.e. they are attached to the same carbon atom or to carbon atoms directly bonded to each other, or they may be further away from each other. Preference is given to such ring formation in radicals attached to carbon atoms directly bonded to each other or to the same carbon atom.
[0009] The statement that two or more radicals may together form a ring should in the context of this specification be understood to mean, inter alia, that the two radicals are linked to each other by a chemical bond involving the formal elimination of two hydrogen atoms, as illustrated by the following scheme: [ka]
[0010] However, the above expression should also be construed to mean that one of the two radicals is hydrogen and the second radical is attached to the position where the hydrogen atom was attached to form a ring, as shown in the following scheme: [ka]
[0011] The formation of the aromatic ring system is illustrated by the following scheme: [ka]
[0012] An aryl group in the context of the present invention comprises 6 to 40 carbon atoms. A heteroaryl group in the context of the present invention comprises 2 to 40 carbon atoms and at least one heteroatom, provided that the sum of carbon atoms and heteroatoms is at least 5. The heteroatoms are preferably selected from N, O and / or S. An aryl or heteroaryl group is understood to mean either a single aromatic ring, i.e. benzene, or a single heteroaromatic ring, such as pyridine, pyrimidine, thiophene, etc., or fused aryl or heteroaryl groups, such as naphthalene, anthracene, phenanthrene, quinoline, isoquinoline, etc.
[0013] An aromatic ring system in the context of the present invention comprises 6 to 40 carbon atoms in the ring system. A heteroaromatic ring system in the context of the present invention comprises 1 to 40 carbon atoms and at least one heteroatom in the ring system, provided that the sum of carbon atoms and heteroatoms is at least 5. The heteroatom is preferably selected from N, O and / or S. An aromatic or heteroaromatic ring system in the context of the present invention is understood to mean not necessarily a system containing only aryl or heteroaryl groups, but also a system in which several aryl or heteroaryl ring systems can be interrupted by non-aromatic units (preferably less than 10% of atoms other than H), such as carbon, nitrogen or oxygen atoms, or carbonyl groups. For example, systems such as 9,9'-spirobifluorene, 9,9-diarylfluorene, triarylamines, diaryl ethers, stilbenes, etc., are therefore considered as aromatic ring systems in the context of the present invention, as are systems in which two or more aryl groups are interrupted, for example, by linear or cyclic alkyl groups or by silyl groups. In addition, systems in which two or more aryl or heteroaryl groups are directly bonded to each other, such as biphenyl, terphenyl, quaterphenyl, or bipyridine, are also considered to be aromatic or heteroaromatic ring systems. Preferred aromatic or heteroaromatic ring systems are aryl or heteroaryl groups and systems in which two or more aryl or heteroaryl groups are directly bonded to each other, as well as fluorene and spirobifluorene groups.
[0014] In the context of this invention a cyclic alkyl group is taken to mean a monocyclic, bicyclic or polycyclic group.
[0015] In the context of the present invention, each hydrogen atom or CH 2 C groups may be replaced by the above-mentioned groups. 1 ~C 20The alkyl group is, for example, methyl, ethyl, n-propyl, i-propyl, cyclopropyl, n-butyl, i-butyl, s-butyl, t-butyl, cyclobutyl, 2-methylbutyl, n-pentyl, s-pentyl, t-pentyl, 2-pentyl, neopentyl, cyclopentyl, n-hexyl, s-hexyl, t-hexyl, 2-hexyl, 3-hexyl, neohexyl, cyclohexyl, 1-methylcyclopentyl, 2-methylpentyl, n-heptyl, 2-heptyl. 3-heptyl, 4-heptyl, cycloheptyl, 1-methylcyclohexyl, n-octyl, 2-ethylhexyl, cyclooctyl, 1-bicyclo[2.2.2]octyl, 2-bicyclo[2.2.2]octyl, 2-(2,6-dimethyl)octyl, 3-(3,7-dimethyl)octyl, adamantyl, trifluoromethyl, pentafluoroethyl, 2,2,2-trifluoroethyl, 1,1-dimethyl-n-hex-1-yl, 1,1-dimethyl-n-hepta- 1-yl, 1,1-dimethyl-n-oct-1-yl, 1,1-dimethyl-n-dec-1-yl, 1,1-dimethyl-n-dodec-1-yl, 1,1-dimethyl-n-tetradec-1-yl, 1,1-dimethyl-n-hexadec-1-yl, 1,1-dimethyl-n-octadec-1-yl, 1,1-diethyl-n-hex-1-yl, 1,1-diethyl-n-hept-1-yl, 1,1-diethyl-n-oct-1-yl, 1,1-diethyl-n-dec-1-yl, 1 , 1-diethyl-n-dodec-1-yl, 1,1-diethyl-n-tetradec-1-yl, 1,1-diethyl-n-hexadec-1-yl, 1,1-diethyl-n-octadec-1-yl, 1-(n-propyl)cyclohex-1-yl, 1-(n-butyl)cyclohex-1-yl, 1-(n-hexyl)cyclohex-1-yl, 1-(n-octyl)cyclohex-1-yl and 1-(n-decyl)cyclohex-1-yl radicals. Alkenyl groups are understood to mean, for example, ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl or cyclooctadienyl.An alkynyl group is understood to mean, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl or octynyl. OR. 1 OR 2 For C, 1 ~C 20 -alkoxy group is understood to mean, for example, methoxy, trifluoromethoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy or 2-methylbutoxy.
[0016] Aromatic or heteroaromatic ring systems having 5 to 40 aromatic ring atoms, which in each case may be substituted by the aforementioned radicals and which may be linked to the aromatic or heteroaromatic system via any position, are, for example, benzene, naphthalene, anthracene, benzanthracene, phenanthrene, benzophenanthrene, pyrene, chrysene, perylene, fluoranthene, benzofluoranthene, naphthacene, pentacene, benzopyrene, biphenyl, biphenylene, terphenyl, terphenylene, fluorene, spirobifluorene. , dihydrophenanthrene, dihydropyrene, tetrahydropyrene, cis- or trans-indenofluorene, cis- or trans-monobenzoindenofluorene, cis- or trans-dibenzoindenofluorene, truxene, isotruxene, spirotruxene, spiroisotruxene, furan, benzofuran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene, pyrrole, indole, isoindole, carbazole, indolocarbazole, indenocarbazole, Pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, phenothiazine, phenoxazine, pyrazole, indazole, imidazole, benzimidazole, naphthoimidazole, phenanthrimidazole, pyridimidazole, pyrazinimidazole, quinoxalineimidazole, oxazole, benzoxazole, naphthoxazole, anthroxazole, phenanthroxazole, isoxazole, 1,2-thiazole, 1,3 -Thiazole, benzothiazole, pyridazine, benzopyridazine, pyrimidine, benzopyrimidine, quinoxaline, 1,5-diazaanthracene, 2,7-diazapyrene, 2,3-diazapyrene, 1,6-diazapyrene, 1,8-diazapyrene, 4,5-diazapyrene, 4,5,9,10-tetraazapyrylene, pyrazine, phenazine, phenoxazine, phenothiazine, fluorubine, naphthyridine, azacarbazole, benzocarboline, phenanthroline, 1,2,3-triazole, 1,2,4-triazole, benzotriazole, 1,2,It is understood to mean radicals derived from 3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,3,4-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, tetrazole, 1,2,4,5-tetrazine, 1,2,3,4-tetrazine, 1,2,3,5-tetrazine, purine, pteridine, indolizine and benzothiadiazole.
[0017] In the context of this application, L 1 or L 2 The term "bidentate ancillary ligand" for V 1 or V 2 The absence of the group indicates that the unit is bidentate. However, formal hydrogen atom abstraction and V 1 or V 2 As a result of the bond to it is not a separate ligand but part of the larger multidentate ligand so formed, and hence the term "ancillary ligand".
[0018] The term "central ancillary ligand" is used above and below and is understood in the present invention to mean any ancillary ligand in the compound of formula (1) that simultaneously coordinates Ir and Pt.
[0019] To further illustrate the compounds of the present invention, two simple structures of formula (1) are shown and described in detail below. [ka]
[0020] In this structure, the central ancillary ligand that coordinates the iridium and platinum is a 2-phenylpyrimidine group. The central ancillary ligand and the two ancillary ligands L 1 Bridging the V 1The group is a 1,3,5-triphenylbenzene group. The central ancillary ligand and ancillary ligand L 2 Bridging the V 2 The group is C(CH 3 ) 2 The two ancillary ligands L 1 is V 1 The subscript n is also bonded to a group, and each of these in the above structure is a phenylpyridine. The subscript n is 1, meaning that this structure contains exactly one platinum atom. In each of the two structures, one subscript m is 1 and the other subscript m is 0, where in the first structure, V 2 The base is V 1 is bonded to the same ring as the V 1 and V 2 The groups are attached to two different rings of the central subligand. In the above structure, iridium is coordinated to two phenylpyridine and one phenylpyrimidine subligand, and platinum is coordinated to one phenylpyridine and one phenylpyrimidine subligand. Here, the phenyl and pyrimidine groups of the phenylpyrimidine coordinate to both iridium and platinum.
[0021] The binding of the ligands to iridium or platinum can be either coordinate or covalent, or the covalent ratio of the bond can vary depending on the ligand. In the present invention, when it is said that a ligand or ancillary ligand is coordinated or bound to iridium or platinum, this refers in the context of this application to any type of binding of the ligand or ancillary ligand to the metal, regardless of the covalent ratio of the bond.
[0022] The compounds of the present invention are preferably uncharged, i.e. electrically neutral. This is achieved so that the charge of the ancillary ligands is complementary to the charge of the metal atom. Thus, for example, it is preferred that an iridium atom in the +3 oxidation state is coordinated to three bidentate ancillary ligands with a total of three negative charges, and a platinum atom in the +2 oxidation state is coordinated to two bidentate ancillary ligands with a total of two negative charges, where the central ancillary ligand that simultaneously coordinates Ir and Pt preferably has two negative charges. Here, the ancillary ligand L 1 and L 2 Alternatively, for example, a central ancillary ligand that coordinates Ir and Pt may be coordinated to Pt through two uncharged nitrogen atoms and L 2 can be coordinated to Pt through two anionic carbon atoms. Similarly, for example, a central ancillary ligand that coordinates to Ir and Pt can be coordinated to Pt through two anionic carbon atoms, and L 2 is coordinated to Pt via two uncharged nitrogen atoms.
[0023] When n=1, the compound of the present invention is a binuclear compound having one iridium atom and one platinum atom. When n=2, the compound of the present invention is a trinuclear compound having one iridium atom and two platinum atoms. When n=3, the compound of the present invention is a tetranuclear compound having one iridium atom and three platinum atoms. In a preferred embodiment of the present invention, n=1.
[0024] In a preferred embodiment of the invention, the compound of formula (1) is selected from the compounds of formula (1') below: [ka] where m=0, the R radical is the corresponding V 2 is attached to the carbon atom to which D will be attached, and the R radical ortho to D may be the same or different for each occurrence and may be H, D (deuterium), F, CH 3 and CDs 3and is preferably H, and the other symbols and indices used have the meanings given above.
[0025] In a preferred form of formula (1), Ir is coordinated by a carbon atom and a nitrogen atom of the central ancillary ligand. In a further preferred form of formula (1), Pt is coordinated by one carbon atom and one nitrogen atom, or by two carbon atoms, of the central ancillary ligand. Thus, the compound of formula (1) preferably has one of the structures of formulae (1a) to (1f) below. [ka] The symbols and subscripts used herein have the meanings described above. Since the central ancillary ligand in formulae (1e) and (1f) coordinates to Pt via two anionic carbon atoms, the ancillary ligand L 2 is coordinated to Pt via two uncharged atoms, specifically the two uncharged nitrogen atoms.
[0026] More preferably, both Ir and Pt are coordinated by one carbon atom and one nitrogen atom of the central ancillary ligand, and the preferred forms are structures of formulae (1a)-(1d).
[0027] In a preferred embodiment, one subscript m is 1 and the other subscript m is 0, and the compounds of the invention preferably contain exactly one V per platinum subcomplex. 2 In addition, there is exactly one V 2 In compounds having a group, it is preferred that this group is bonded to an aryl or heteroaryl group on the central ancillary ligand, which is coordinated to Ir via a carbon atom. Thus, preferred compounds are those of the following formulae (1a-1) to (1f-1): [ka] The symbols and indices used herein have the meanings given above.
[0028] In a preferred embodiment of the invention, X in formulae (1a) to (1f) is CR, and therefore the structures are preferably selected from the compounds of formulae (1a-2) to (1f-2). [ka] where m=0, the R radical is the corresponding V 2 is attached to the carbon atom to which D will be attached, and the R radical ortho to D may be the same or different for each occurrence and may be H, D (deuterium), F, CH 3 and CDs 3 and is preferably H, and the other symbols and indices used have the meanings given above.
[0029] Particularly preferred are the compounds of the following formulas (1a-3) to (1f-3). [ka] The symbols and subscripts used herein have the meanings given above, where the R radicals ortho to D are preferably identical or different at each occurrence and are H, D (deuterium), F, CH 3 and CDs 3 and more preferably H.
[0030] Below, V 1 As described above, the preferred forms of the V 1 connects the central annular ligand and two annular ligands together when n=1, or connects the two central annular ligands and annular ligand L 1 to each other, or, when n=3, to each other, the three central ancillary ligands.
[0031] In a preferred embodiment of the present invention, V 1 is selected from the groups of formulas (2) and (3) below. [ka] Here, the dotted bonds are to the central subligand or to the subligand L 1 where R has the meaning given above, and other symbols used are as follows: A is the same or different at each occurrence, -CR=CR-, -C(=O)-NR'-, -C(=O)-O-, -CR 2 -CR 2 -, -CR 2 -O-, or a group of formula (4): [ka] Here, the dotted bond indicates the linkage between the central antimeligand or antimeligand L 1 to this structure, and * indicates the point of attachment to the central ring group of the unit of formula (4), i.e., a group explicitly included in formula (2) or (3); X 1 is the same or different at each occurrence and is CR or N; X 2 are identical or different for each occurrence, are CR or N, or are separated by two adjacent X 2 The groups together are NR, O or S to form a 5-membered ring, and the remaining X 2 is the same or different at each occurrence and is CR or N; or X in a ring 3 When one of the groups is N, two adjacent X 2 The groups are both CR or N and form a 5-membered ring; provided that there are no more than two adjacent X 2 The group is N; X 3 is either C for each occurrence or one X 3 The group is N and there are no other X groups in the same ring. 3 The group is C; provided that X in the ring 3 If one of the groups is N, then the two adjacent X 2 both groups are CR or N; A 1 are identical or different for each occurrence, and C(R) 2 or O; A 2is the same or different at each occurrence and is CR, P(=O), B or SiR, where A 2 =P(=O), B or SiR, symbol A 1 is O and this A 2 The symbol A attached to is not -C(=O)-NR'- or -C(=O)-O-; R' may be the same or different at each occurrence and is H, D, a linear alkyl group having 1 to 20 carbon atoms, or a branched or cyclic alkyl group having 3 to 20 carbon atoms, where in each case the alkyl group is one or more of R 1 radicals, and wherein one or more non-adjacent CH 2 The group is Si(R 1 ) 2 or having 5 to 40 aromatic ring atoms, in each case having one or more R 1 It is an aromatic or heteroaromatic ring system, optionally substituted by radicals.
[0032] A in formula (3) 2 If is CR, then all A 2 If is CR, then specifically A 1 0, 1, 2 or 3 of these, especially 3 are CR 2 If A 2 The R radicals above can take different positions depending on the conformation. Preferred here are small R radicals such as H or D. It is preferred that they either all point away from the metal (apical) or all point inwards towards the metal (endohedral). This is shown below by an example where each A group is an ortho-phenylene group. [ka]
[0033] For clarity, the third ancillary ligand coordinated to Ir or Pt is not shown, but is simply shown as a dotted bond. Thus, preferred are complexes that can adopt at least one of two conformations. These are complexes in which all three ancillary ligands are in equatorial conformations on the central ring.
[0034] Preferred forms of the group of formula (2) are the structures of the following formulae (5) to (8), and preferred forms of the group of formula (3) are the structures of the following formulae (9) to (13). [ka] Here, the symbols have the meanings given above.
[0035] Preferred R radicals in formulas (2), (3) and (5)-(13) are as follows: R is the same or different for each occurrence and is H, D, F, CN, OR 1 a linear alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, or a branched or cyclic alkyl group having 3 to 10 carbon atoms, each of which may be one or more of R 1 or 5 to 24 aromatic ring atoms, and in each case one or more R 1 an aromatic or heteroaromatic ring system, optionally substituted by radicals; R 1 are the same or different for each occurrence, H, D, F, CN, OR 2 , a straight chain alkyl group having 1 to 10 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, or a branched or cyclic alkyl group having 3 to 10 carbon atoms, each of which may be represented by one or more R 2 or 5 to 24 aromatic ring atoms, and in each case one or more R 2 an aromatic or heteroaromatic ring system, optionally substituted by a radical; at the same time, two or more adjacent R 1the radicals together may form a ring system; R 2 is the same or different at each occurrence and is H, D, F, or an aliphatic, aromatic, or heteroaromatic organic radical having 1 to 20 carbon atoms (wherein one or more hydrogen atoms can be replaced by F).
[0036] Particularly preferred R radicals in formulas (2), (3) and (5)-(13) are as follows: R may be the same or different at each occurrence and is H, D, F, CN, a straight chain alkyl group having 1 to 4 carbon atoms, or a branched or cyclic alkyl group having 3 to 6 carbon atoms, each of which may be one or more of R 1 or 6 to 12 aromatic ring atoms, and in each case one or more R 1 an aromatic or heteroaromatic ring system, optionally substituted by radicals; R 1 are the same or different at each occurrence and are H, D, F, CN, a straight chain alkyl group having 1 to 4 carbon atoms, or a branched or cyclic alkyl group having 3 to 6 carbon atoms, each of which may be represented by one or more R 2 or 6 to 12 aromatic ring atoms, and in each case one or more R 2 an aromatic or heteroaromatic ring system, optionally substituted by a radical; at the same time, two or more adjacent R 1 the radicals together may form a ring system; R 2 is the same or different at each occurrence and is H, D, F, or an aliphatic or aromatic hydrocarbon radical having 1 to 12 carbon atoms.
[0037] In a preferred embodiment of the present invention, all X in the group of formula (2) 1 The group is CR, and therefore the central trivalent ring of formula (2) is benzene. More preferably, all X 1The radicals are CH or CD, in particular CH. In a further preferred embodiment of the invention, all radicals X 1 is a nitrogen atom, and therefore the central trivalent ring of formula (2) is a triazine. Preferred forms of formula (2) are therefore the structures of formulas (5) and (6) shown above. More preferably, the structure of formula (5) is the structure of formula (5') below. [ka] Here, the symbols have the meanings given above.
[0038] In a further preferred embodiment of the present invention, all A in the group of formula (3) 2 The group is CR. More preferably, all A 2 The group is CH. A preferred form of formula (3) is therefore the structure of formula (9) shown above. More preferably, the structure of formula (9) is the structure of formula (9') or (9'') below. [ka] wherein the symbols have the meanings given above and R is preferably H.
[0039] As already mentioned above, the R radicals in these structures may form ring systems together, for example through ring formation with the R radicals in formula (9') it is possible to form an adamantane bridgehead, as shown in the following two formulae: [ka]
[0040] Preferred A groups, as present in the structures of formulae (2) and (3) and (5)-(13), are described below. The A groups are the same or different in each occurrence and can be an alkenyl group, an amide group, an ester group, an alkylene group, a methylene ether group, or an ortho-linked arylene or heteroarylene group of formula (4). When A is an alkenyl group, it is a cis-linked alkenyl group. In the case of asymmetric A groups, any orientation of the group is possible. For example, when A is -C(=O)-O-, either the carbon atom or the carbonyl group can be attached to the central ancillary ligand or ancillary ligand L. 1 The same can be done by combining A=-N(R 1 This also applies to the case of --C(.dbd.O)--.
[0041] In a preferred embodiment of the invention, the A groups are in each case identical or different at each occurrence, preferably identical, and are -CR 2 -CR 2 -, -C(=O)-O-, -C(=O)-NR'- or a group of formula (4). More preferably, all A groups are identical and have the same substitution. Preferred combinations of A groups in formulas (2) and (3), and preferred forms thereof, are as follows: [ka]
[0042] When A is -C(=O)-NR'-, R' is identical or different in each occurrence and is a linear alkyl group having 1 to 10 carbon atoms, or a branched or cyclic alkyl group having 3 to 10 carbon atoms, or an aromatic ring atom having 6 to 24, and in each case, one or more R 1 More preferably, R' is identical or different at each occurrence and is a linear alkyl group having 1 to 5 carbon atoms, or a branched or cyclic alkyl group having 3 to 6 carbon atoms, or an aromatic ring system having 6 to 12 ring atoms, in each case containing one or more R 1The radical is an aromatic or heteroaromatic ring system which may be substituted, but is preferably unsubstituted.
[0043] The preferred form of the group of formula (4) is described below. The group of formula (4) can represent a 5-membered heteroaromatic ring, or an aromatic or heteroaromatic 6-membered ring. In the preferred form of the present invention, the group of formula (4) contains up to two heteroatoms in the aromatic or heteroaromatic unit, more preferably up to one heteroatom. This does not mean that any substituent attached to this group cannot also contain heteroatoms. Moreover, this does not mean that the ring formation by the substituent cannot give rise to a fused aromatic or heteroaromatic structure, such as naphthalene, benzimidazole, etc.
[0044] X in formula (4) 3 When both X groups are carbon atoms, preferred forms of the group of formula (4) are structures of the following formulae (14) to (30), and one X 3 The group is a carbon atom and is not adjacent to other X groups in the same ring. 3 When the group is a nitrogen atom, preferred forms of the group of formula (4) are structures of the following formulae (31) to (38). [ka] Here, the symbols have the meanings given above.
[0045] Particularly preferred are the 6-membered aromatic and heteroaromatic rings of the above formulae (14) to (18). Especially preferred is ortho-phenylene, i.e., the group of the above formula (14).
[0046] At the same time, adjacent R substituents can also form a ring system together, thus forming fused structures including fused aryl and heteroaryl groups, such as naphthalene, quinoline, benzimidazole, carbazole, dibenzofuran or dibenzothiophene. Such ring formation is shown diagrammatically below in the group of formula (14) above, which can lead, for example, to groups of formulae (14a) to (14j) below: [ka] Here, the symbols have the meanings given above.
[0047] In general, as shown by the fused benzo groups in formulae (14a)-(14c), the fused groups can be fused at any position of the unit of formula (4). Groups such as those fused to the unit of formula (4) in formulae (14d)-(14j) can therefore also be fused at other positions of the unit of formula (4).
[0048] A preferred group of formula (2) is a group of formula (5), and a preferred group of formula (3) is a group of formula (9). The group of formula (5) can more preferably be represented by the following formulae (5a) to (5x), and the group of formula (9) can more preferably be represented by the following formulae (9a) to (9x). [ka] [ka] [ka] [ka] where the symbols have the meanings given above. Preferably, X 2 is the same or different at each occurrence and is CR, particularly CH.
[0049] In the above structure where two A groups are identical and the third A group is different from the first two A groups, when n=1, both identical A groups are L 1 It is preferred that the A group is bonded to the central annular ligand and is different from the first A group. Furthermore, when n=2, the same A group is bonded to both central annular ligands and is different from the first A group. 1 It is preferred to bind to
[0050] A particularly preferred form of the group of formula (2) is the group of formula (5a″): [ka] Here, the symbols have the meanings given above.
[0051] More preferably, the R groups in the above formula are the same or different and are H, D or an alkyl group having 1 to 4 carbon atoms. Most preferably, R is H. Especially preferred are therefore structures of formula (5a''') below: [ka] Here, the symbols have the meanings given above.
[0052] More suitable bridgehead V 1 is expressed by the following formula (V 1 -a) structure. [ka] where A and R have the meanings given above and V is CR, N, SiR, P or P=O, preferably CR or N. In this case, the R explicitly shown on the methylene group is preferably H.
[0053] After that, V 2 As described above, the preferred forms of the V 2 is a divalent radical or a central ancillary ligand and ancillary ligand L 2 is a single bond that connects the
[0054] In a preferred embodiment of the present invention, V 2 is a divalent radical. It is preferably 2 , NR, O, S, Se, -CR 2 -CR 2 -, -CR 2 -O-, -CR=CR- or an ortho-linked arylene or heteroarylene group having 5 or 6 aromatic ring atoms and optionally substituted by one or more R radicals. 2 When is an ortho-linked arylene or heteroarylene group, the preferred forms are those groups described above as the preferred forms of the structure of formula (4).
[0055] If one subscript m is 1 and the other is 0, then for m=1, the corresponding V 2 The groups are NR, CR 2 , O and S, more preferably NR, CR 2 and O.
[0056] If both subscripts m are 1, then V 2 One of the groups is CR 2 , NR, O or S, more preferably CR 2 or NR, and other V 2 The group is -CR 2 -CR 2 -, -CR 2 Preferred are when selected from the group consisting of -O-, -CR=CR- or an ortho-linked arylene or heteroarylene group having 5 or 6 aromatic ring atoms and optionally substituted by one or more R radicals.
[0057] V 2 But, CR 2 , -CR 2 -CR 2 -, -CR 2 In the case of -O- or -CR=CR- groups, preferred R radicals are identical or different at each occurrence and have 1 to 10 carbon atoms and one or more R1 an alkyl group optionally substituted by a radical, or an aromatic ring having 5 to 13 atoms and one or more R 1 In this case, it is also possible for several R radicals attached to the same carbon atom or to two adjacent carbon atoms to form a ring system together. More preferably, these R radicals are the same or different at each occurrence and are selected from the group consisting of H, an alkyl group having 1 to 5 carbon atoms, and a ring system having 5 to 10 aromatic ring atoms and one or more R 1 Aromatic or heteroaromatic ring systems, optionally substituted by R radicals, wherein multiple R radicals attached to the same carbon atom or to two adjacent carbon atoms can also form a ring system together.
[0058] V 2 When is an NR group, preferred R radicals have 1 to 10 carbon atoms and one or more R 1 an alkyl group optionally substituted by a radical, or an aromatic ring having 5 to 24 atoms and one or more R 1 More preferably, these R radicals are selected from the group consisting of aromatic or heteroaromatic ring systems having 5 to 13 aromatic ring atoms, more preferably 6 to 10 aromatic ring atoms, which in each case ... 1 and optionally substituted by a radical.
[0059] bidentate subligand L 1 and L 2 The ancillary ligands L are described below. 1 and L 2 may be the same or different. The two ancillary ligands L 1 In a preferred embodiment of the invention, the bidentate ancillary ligands L 1In a further preferred embodiment of the invention, the bidentate ancillary ligand L 2 is monoanionic or uncharged.
[0060] In a further preferred embodiment of the invention, the bidentate ancillary ligand L 1 and L 2 The coordination atoms of are the same or different at each occurrence and are selected from C, N, P, O, S and / or B, more preferably C, N and / or O, and most preferably C and / or N. 1 Each of the bidentate ancillary ligands L preferably has one carbon atom and one nitrogen atom, or two carbon atoms, or two nitrogen atoms, or two oxygen atoms, or one oxygen atom and one nitrogen atom, as coordinating atoms. 2 Each of the ancillary ligands L preferably has one carbon atom and one nitrogen atom, or two nitrogen atoms, as coordinating atoms. 1 and L 2 Each of the coordination atoms of the bidentate ancillary ligands L may be the same or different. 1 at least one of the ancillary ligands has one carbon atom and one nitrogen atom or two carbon atoms, in particular one carbon atom and one nitrogen atom, as coordination atoms. More preferably, all bidentate ancillary ligands have one carbon atom and one nitrogen atom or two carbon atoms, in particular one carbon atom and one nitrogen atom, as coordination atoms. Particularly preferred are therefore metal complexes in which all ancillary ligands are orthometalated, i.e. in which at least one metal-carbon bond is present, forming a metallacycle with Ir or Pt.
[0061] More preferably, iridium or platinum is combined with a bidentate ancillary ligand L 1 or L 2 is preferably a 5-membered metallocycle, particularly when the coordinating atoms are C and N, N and N, or N and O. When the coordinating atom is O, a 6-membered metallocycle is also preferred. This is shown diagrammatically below. [ka] where M is Ir or Pt, N is a coordinating nitrogen atom, C is a coordinating carbon atom, and O represents a coordinating oxygen atom, and the indicated carbon atom is a bidentate ancillary ligand L 1 or L 2 is an atom of.
[0062] In a preferred embodiment of the present invention, L 2 and at least one bidentate ancillary ligand L 1 , more preferably all bidentate ancillary ligands L 1 is the same or different at each occurrence and is selected from structures of formulae (L-1), (L-2), and (L-3) below. [ka] Here, the dotted bonds represent the ancillary ligands L 1 V 1 or an ancillary ligand L 2 V 2 Other symbols used indicate bonds to and are as follows: CyC, which may be the same or different at each occurrence, is a substituted or unsubstituted, aryl or heteroaryl group having 5 to 14 aromatic ring atoms and is coordinated to M via a carbon atom and bonded to CyD via a covalent bond; CyD is the same or different at each occurrence and is a substituted or unsubstituted heteroaryl group having 5 to 14 aromatic ring atoms and is coordinated to M via a nitrogen atom or via a carbene carbon atom and is bonded to CyC via a covalent bond; At the same time, two or more optional substituents may together form a ring system; furthermore, the optional radicals are preferably selected from the R radicals listed above.
[0063] At the same time, CyD in the ancillary ligands of formulae (L-1) and (L-2) is preferably coordinated via an uncharged nitrogen atom or via a carbene carbon atom, in particular via an uncharged nitrogen atom.More preferably, one of the two CyD groups in the ligand of formula (L-3) is coordinated via an uncharged nitrogen atom, and the other of the two CyD groups is coordinated via an anionic nitrogen atom, or both CyD groups are coordinated via an uncharged nitrogen atom.More preferably, CyC in the ancillary ligands of formulae (L-1) and (L-2) is coordinated via an anionic carbon atom.
[0064] When two or more substituents, especially two or more R radicals, together form a ring system, the ring system can be formed from the substituents attached to the directly adjacent carbon atoms. Furthermore, it is also possible that the substituents on CyC and CyD in formulas (L-1) and (L-2) or on the two CyD groups in formula (L-3) together form a ring, so that CyC and CyD or the two CyD groups or the two CyC groups also together form a single fused aryl or heteroaryl group as a bidentate ligand.
[0065] In a preferred embodiment of the invention, CyC is an aryl or heteroaryl group having 6 to 13 aromatic ring atoms, more preferably 6 to 10 aromatic ring atoms, most preferably 6 aromatic ring atoms, in particular a phenyl group, which is coordinated to the metal via a carbon atom, optionally substituted by one or more R radicals, and which is bonded to CyD via a covalent bond.
[0066] Preferred forms of the CyC group are structures of the following formulae (CyC-1) to (CyC-20). [ka] where CyC is in each case bonded to the position in CyD indicated with # and coordinates to the metal at the position indicated with *, R has the meaning given above and further symbols used are as follows: X is the same or different at each occurrence and is CR or N, provided that not more than two symbols X per ring are N; W is NR, O or S; However, the auxiliary ligand L 1 via CyC 1 When combined with V, one symbol X is C and 1 is attached to this carbon atom, and further with the proviso that the ancillary ligand L 2 via CyC 2 When combined with V, one symbol X is C and 2 is attached to this carbon atom. 1 via the CyC group 1 When L is bonded to the above formula, this bond is preferably via the position marked with "o" in the above formula, and therefore in that case the symbol X marked with "o" is preferably C. 1 The above structure is preferably 1 The ancillary ligands L are not directly bonded to the bridge because such a bond to the bridge is not favorable for steric reasons. 2 But, V 2 via a CyC group, the attachment is preferably via a position ortho to the coordination to Pt.
[0067] Preferably, a total of no more than two symbols X in CyC are N, more preferably, no more than one symbol X in CyC is N, and most preferably, all symbols X are CR, with the proviso that CyC is V. 1 or V 2 When directly attached to one symbol X, it is C and V 1 or V 2 is attached to this carbon atom.
[0068] Particularly preferred CyC groups are those of the following formulae (CyC-1a) to (CyC-20a): [ka] [ka] where the symbols have the meanings given above, except that the ancillary ligand L 1 But, V 1 When the compound is bound to CyC, one R radical is absent and V 1 is attached to the corresponding carbon atom, and further with the proviso that the ancillary ligand L 2 But, V 2 When the compound is bound to CyC, one R radical is absent and V 2 is attached to the corresponding carbon atom. 1 V 1 via a CyC group, the bond is preferably via the position marked with "o" in the above formula, and therefore, in that case, the R radical marked with "o" is preferably absent. 1 The above structure is preferably 1 The ancillary ligands L are not directly bonded to the bridge because such a bond to the bridge is not favorable for steric reasons. 2 But, V 2 When attached to CyC via CyC, the attachment is preferably via a position ortho to the coordination to Pt.
[0069] Among the (CyC-1) to (CyC-20) groups, preferred are (CyC-1), (CyC-3), (CyC-8), (CyC-10), (CyC-12), (CyC-13) and (CyC-16) groups, and particularly preferred are (CyC-1a), (CyC-3a), (CyC-8a), (CyC-10a), (CyC-12a), (CyC-13a) and (CyC-16a) groups.
[0070] In a further preferred embodiment of the invention, CyD is a heteroaryl group having 5 to 13 aromatic ring atoms, more preferably 6 to 10 aromatic ring atoms, which is coordinated to the metal via an uncharged nitrogen atom or via a carbene carbon atom and which may be substituted by one or more radicals R and which is attached to CyC via a covalent bond.
[0071] Preferred forms of the CyD group are structures of the following formulae (CyD-1) to (CyD-14). [ka] wherein the CyD group is in each case bonded to the position in CyC indicated with # and coordinates to the metal at the position indicated with *, and wherein X, W and R have the meanings given above, except that the ancillary ligand L 1 CyD via V 1 When combined with V, one symbol X is C and 1 is attached to this carbon atom, and further with the proviso that the ancillary ligand L 2 CyD via V 2 When combined with V, one symbol X is C and 2 is attached to this carbon atom. 1 via the CyD group 1 When L is bonded to the above formula, this bond is preferably via the position marked with "o" in the above formula, and therefore in that case the symbol X marked with "o" is preferably C. 1 The above structure is preferably 1 The ancillary ligands L are not directly bonded to the bridge because such a bond to the bridge is not favorable for steric reasons. 2 But, V 2 When attached to the Pt via a CyD group, the attachment is preferably via a position ortho to the coordination to Pt.
[0072] In this case, the (CyD-1)-(CyD-4), (CyD-7)-(CyD-10), (CyD-13) and (CyD-14) groups are coordinated to the metal via uncharged nitrogen atoms, the (CyD-5) and (CyD-6) groups via carbene carbon atoms, and the (CyD-11) and (CyD-12) groups via anionic nitrogen atoms.
[0073] Preferably, a total of not more than two symbols X in CyD are N, more preferably, not more than one symbol X in CyD is N, and especially preferred, all symbols X are CR, with the proviso that CyD is V. 1 or V 2 When connected to V, one of the symbols X is C and 1 or V 2 is attached to this carbon atom.
[0074] Particularly preferred CyD groups are those of the following formulae (CyD-1a) to (CyD-14b): [ka] wherein the symbols used have the meanings given above and CyD is V 1 or V 2 When bonded to V, one R radical is absent and V 1 or V 2 is attached to the corresponding carbon atom. 1 V 1 via a CyD group, the attachment is preferably via the position marked with "o" in the above formula, and therefore, in that case, the R radical marked with "o" is preferably absent. 1 The above structure is preferably 1 The ancillary ligands L are not directly bonded to the bridge because such a bond to the bridge is not favorable for steric reasons. 2 But, V 2 When attached to the Pt via CyD, the attachment is preferably via a position ortho to the coordination to Pt.
[0075] Among the (CyD-1) to (CyD-14) groups, preferred are the (CyD-1), (CyD-2), (CyD-3), (CyD-4), (CyD-5) and (CyD-6) groups, in particular the (CyD-1), (CyD-2) and (CyD-3) groups, and particularly preferred are the (CyD-1a), (CyD-2a), (CyD-3a), (CyD-4a), (CyD-5a) and (CyD-6a) groups, in particular the (CyD-1a), (CyD-2a) and (CyD-3a) groups.
[0076] In a preferred embodiment of the invention, CyC is an aryl or heteroaryl group having 6 to 13 aromatic ring atoms and at the same time CyD is a heteroaryl group having 5 to 13 aromatic ring atoms. More preferably, CyC is an aryl or heteroaryl group having 6 to 10 aromatic ring atoms and at the same time CyD is a heteroaryl group having 5 to 10 aromatic ring atoms. Most preferably, CyC is an aryl or heteroaryl group having 6 aromatic ring atoms, in particular a phenyl group, and CyD is a heteroaryl group having 6 to 10 aromatic ring atoms. At the same time, CyC and CyD may be substituted by one or more R radicals.
[0077] The above preferred groups (CyC-1) to (CyC-20) and (CyD-1) to (CyD-14) may be combined with one another in the annular ligands of formulae (L-1) and (L-2), if desired, provided that at least one of the CyC or CyD groups is V 1 or V 2 It is particularly preferred when the CyC and CyD groups identified above as being particularly preferred, i.e. groups of formulae (CyC-1a) to (CyC-20a) and groups of formulae (CyD1-a) to (CyD-14b), are combined with one another, with the proviso that at least one of the preferred CyC or CyD groups is selected from the group consisting of V 1 or V 2 It has a suitable attachment site for the group.
[0078] Also particularly preferred is when one of the (CyC-1), (CyC-3), (CyC-8), (CyC-10), (CyC-12), (CyC-13) and (CyC-16) groups, in particular the (CyC-1a), (CyC-3a), (CyC-8a), (CyC-10a), (CyC-12a), (CyC-13a) and (CyC-16a) groups, is combined with one of the (CyD-1), (CyD-2) and (CyD-3) groups, and in particular with one of the (CyD-1a), (CyD-2a) and (CyD-3a) groups.
[0079] Preferred ancillary ligands (L-1) are structures of the following formulae (L-1-1) and (L-1-2), and preferred ancillary ligands (L-2) are structures of the following formulae (L-2-1) to (L-2-3). [ka] where the symbols used have the meanings described above, * indicates the position of coordination to Ir or Pt, and "о" indicates that the structure is L 1 When the form is V 1 This structure shows the bond position to L 2 If the form is V 2 is preferably attached in the ortho position relative to the coordination to Pt. In this case, V 1 or V 2 The symbol X to which is attached is C.
[0080] More preferably, in these structures, X is the same or different at each occurrence and is CR, and therefore the structures are preferably structures of the following formulae (L-1-1a) to (L-2-3a): [ka] where the symbols used have the meanings described above, and "o" indicates that the structure is L 1 When the form is V 1 This structure shows the bond position to L 2 If the form is V 2is preferably attached in the ortho position relative to the coordination to Pt. In this case, V 1 or V 2 There is no R radical on the carbon atom to which is attached.
[0081] Similarly, the above preferred CyD groups in the anionic ligand of formula (L-3) can be linked together, if desired, by linking an uncharged CyD group, i.e., (CyD-1) to (CyD-10), (CyD-13) or (CyD-14) group with an anionic CyD group, i.e., (CyD-11) or (CyD-12) group, or by linking two uncharged CyD groups together, provided that at least one of the CyD groups is V 1 or V 2 It has a suitable binding site for
[0082] When two R radicals (one of which is bonded to CyC and the other to CyD in formula (L-1) and (L-2) or one of which is bonded to one of the CyDs and the other to the other CyD in formula (L-3)) form an aromatic ring system with each other, this results in a bridged ancillary ligand and also in an ancillary ligand which, taken together, represents a single larger heteroaryl group, such as, for example, benzo[h]quinoline. The ring formation between the substituents on CyC and CyD in formula (L-1) and (L-2) or between the substituents on the two CyD groups in formula (L-3) is preferably via a group according to one of the following formulae (39) to (48): [ka] Here, R 1 has the above meaning, and the dotted bond indicates a bond to CyC or CyD. At the same time, asymmetries in the above groups can be incorporated into each of the two possible options; for example, in the group of formula (48), the oxygen atom may be bonded to the CyC group and the carbonyl group may be bonded to the CyD group, or the oxygen atom may be bonded to the CyD group and the carbonyl group may be bonded to the CyC group.
[0083] At the same time, the group of formula (45) is particularly preferred when it results in a six-membered ring upon ring formation, for example as shown below by formulae (L-22) and (L-23).
[0084] Preferred ligands resulting from ring formation between two R radicals on different rings are structures of the following formulae (L-4) to (L-31): [ka] [ka] Here, the symbols used have the meanings described above, and "o" stands for L 1 In the case of the form 1 This structure gives the position where L binds to 2 If it is in the form of V 2 is preferably attached ortho to the ligand to Pt. In this case, V 1 or V 2 The symbol X to which is attached is a carbon.
[0085] In a preferred embodiment of the ancillary ligands of formulae (L-4) to (L-31), a total of one symbol X is N and the other symbols X are CR, or all of the symbols X are CR.
[0086] In a further embodiment of the invention, in the groups (CyC-1) to (CyC-20) or (CyD-1) to (CyD-14) or in the ancillary ligands (L-1-1) to (L-2-3) and (L-4) to (L-31), it is preferred that one of the atoms X is N, provided that the R group attached as a substituent adjacent to this nitrogen atom is not hydrogen or deuterium. This applies analogously to the preferred structures (CyC-1a) to (CyC-20a) or (CyD-1a) to (CyD-14b), in which it is preferred that the substituent attached adjacent to the non-coordinated nitrogen atom is an R group that is not hydrogen or deuterium. In this case, this substituent R is preferably CF 3 , OR 1 (R 1 is a group selected from alkyl groups having 1 to 10 carbon atoms), alkyl groups having 1 to 10 carbon atoms, in particular branched or cyclic alkyl groups having 3 to 10 carbon atoms, dialkylamino groups having 2 to 10 carbon atoms, aromatic or heteroaromatic ring systems, or aralkyl or heteroaralkyl groups. These groups are sterically bulky groups. More preferably, this R radical may also form a ring with the adjacent R radical.
[0087] Further preferred bidentate ancillary ligands L 1 or L 2 is an ancillary ligand of the following formula (L-32) or (L-33): [ka] where R has the above meaning, * represents the position of coordination to the metal, and "o" represents L 1 In the case of the form 1 and other symbols are as follows: X is the same or different at each occurrence and is CR or N, provided that at most one symbol X per ring is N, provided that one symbol X is C and this ancillary ligand is connected to V through this carbon atom. 1 or V 2 is bonded to
[0088] (L-32) or (L-33) is L 2 When the V atom is in the form of 2 The bond to is ortho to this carbon atom.
[0089] When two R radicals bonded to adjacent carbon atoms in the ancillary ligands (L-32) and (L-33) form an aromatic ring with each other, this ring, together with its two adjacent carbon atoms, preferably has a structure of the following formula (49): [ka] where the dotted bond represents the attachment of this group within the ancillary ligand, and Y is the same or different at each occurrence, and CR 1 or N, where preferably at most one symbol Y is N. In a preferred form of the ancillary ligand (L-32) or (L-33), at most one group of formula (50) is present. In a preferred form of the invention, in the ancillary ligands of formulae (L-32) and (L-33), the symbols X, in total 0, 1 or 2, and Y, if present, are N. More preferably, the symbols X, in total 0 or 1, and Y, if present, are N.
[0090] Further preferred bidentate ancillary ligands L 1 or L 2 is a structure of the following formulae (L-34) to (L-38), in which preferably two bidentate ancillary ligands L 1 At most one of these structures. [ka] where the ancillary ligands (L-34) to (L-36) are coordinated to the metal via the nitrogen atom and the negatively charged oxygen atom, respectively, as explicitly shown, and the ancillary ligands (L-37) and (L-38) are coordinated to the metal via two oxygen atoms, X has the above meaning, and "o" is an ancillary ligand L 1 But through it, V 1or an ancillary ligand L 2 V 2 (L-35) is the bond position of L 2 If it is in the form of V 2 is preferably a single bond.
[0091] Preferred ancillary ligands of the formulae (L-34) to (L-36) are the ancillary ligands of the following formulae (L-34a) to (L-36a): [ka] where the symbols used have the above meanings and "o" represents the ancillary ligand L 1 But through it, V 1 or an ancillary ligand L 2 V 2 The binding positions are shown in.
[0092] More preferably, in these formulas, R is hydrogen, where "o" is an ancillary ligand L 1 But through it, V 1 or an ancillary ligand L 2 V 2 The bonding position is shown in, and therefore, the structure is that of the following formulae (L-34b) to (L-36b). [ka] The symbols used herein have the meanings given above.
[0093] An ancillary ligand L, which is a monoanionic ancillary ligand 1 and / or L 2 When is coordinated to iridium or platinum via two nitrogen atoms, these are preferably identical or different and are one of the following formulae (L-39), (L-40) and (L-41): [ka] where X and R 1has the meaning given above, and wherein not more than one X group per ring is N, and R B are identical or different for each occurrence, F, OR 1 , a linear alkyl group having 1 to 10 carbon atoms or a branched or cyclic alkyl group having 3 to 10 carbon atoms, where the alkyl group is in each case one or more R 1 or 5 to 24 aromatic ring atoms, and in each case one or more R 1 and at the same time, two R B The radicals may form links together. In this case, the ancillary ligand coordinates to the iridium or platinum via the two nitrogen atoms marked with *.
[0094] Next, preferred substituents which may be present on the above-mentioned ancillary ligands and on A when A is a group of formula (4) are described.
[0095] In one embodiment of the invention, the compounds of the invention contain two substituents R attached to adjacent carbon atoms and forming together an aliphatic ring according to one of the formulae described hereinafter. In this case, the two substituents R forming this aliphatic ring are linked to one or more bidentate ancillary ligands L of formula (2) or (3) or on the bridge of the preferred form. 1 and / or L 2 The aliphatic ring formed by two substituents R together through ring formation is preferably described by one of the following formulae (50) to (56). [ka] Here, R 1 and R 2 has the meaning given above, the dotted bond denotes the bond between two carbon atoms in the ligand, and further: Z 1 , Z 3are the same or different for each occurrence, and C(R 3 ) 2 ,O.S.,NR. 3 or C(=O); Z 2 is C(R 1 ) 2 ,O.S.,NR. 3 or C(=O); G has 1, 2 or 3 carbon atoms and one or more R 2 an alkylene group optionally substituted with a radical, -CR 2 =CR 2 - or has 5 to 14 aromatic ring atoms and at least one R 2 an ortho-linked arylene or heteroarylene group optionally substituted with a radical; R 3 are identical or different at each occurrence and are H, F, a linear alkyl or alkoxy group having 1 to 10 carbon atoms, a branched or cyclic alkyl or alkoxy group having 3 to 10 carbon atoms, where the alkyl or alkoxy group is in each case composed of one or more R 2 radical, wherein one or more non-adjacent CH 2 The group is R 2 C=CR 2 , C≡C, Si(R 2 ) 2 , C=O, NR 2 , O, S, or CONR 2 or having 5 to 24 aromatic ring atoms, and in each case, one or more R 2 an aromatic or heteroaromatic ring system, or a ring system having 5 to 24 aromatic ring atoms, optionally substituted by radicals, and in each case one or more R 2 an aryloxy or heteroaryloxy group, optionally substituted by a radical; 3 The radicals together may form an aliphatic or aromatic ring system, thus forming a spiro system; furthermore, R 3is the adjacent radical R or R 1 together may form an aliphatic ring system; With the proviso that the two heteroatoms in these groups are not directly bonded to each other, and the two C=O groups are not directly bonded to each other.
[0096] In a preferred embodiment of the invention, R 3 is not H.
[0097] In the above structures of formulae (50)-(56), and in further forms of these structures identified as preferred, a double bond is formally depicted between two carbon atoms. This is a simplification of the chemical structure when these two carbon atoms are incorporated into an aromatic or heteroaromatic system, and therefore the bond between these two carbon atoms is formally between the bond level of a single bond and the bond level of a double bond. The depiction of a formal double bond should therefore not be interpreted as limiting the structure; rather, it will be clear to one skilled in the art that this is an aromatic bond.
[0098] If adjacent radicals in the structures of the invention form an aliphatic ring system, it is preferred if the latter does not have an acidic benzylic proton. A benzylic proton is understood to mean a proton bonded to a carbon atom directly bonded to a ligand. This is achieved by a carbon atom of the aliphatic ring system directly bonded to an aryl or heteroaryl group that is fully substituted and does not contain any bonded hydrogen atoms. The absence of an acidic benzylic proton in formulae (50) to (52) therefore corresponds to the absence of Z 1 and Z 3 C(R 3 ) 2 (R 3 is not hydrogen), then Z 1 and Z 3This is further achieved by the carbon atom of the aliphatic ring system directly bonded to an aryl or heteroaryl group, which is a bridgehead in the bicyclic or polycyclic structure. The protons attached to the bridgehead carbon atoms are, due to the steric structure of the bicyclic or polycyclic structure, much less acidic than the benzylic protons on the unbonded carbon atoms in the bicyclic or polycyclic structure, and are considered as non-acidic protons in the context of the present invention. Thus, the absence of acidic benzylic protons in formulae (53)-(56) is achieved by the bicyclic structure, and as a result, the corresponding anion of the bicyclic structure is not mesomerically stabilized, so that R 1 When it is H, it is much less acidic than the benzylic proton. R in formulas (53)-(56) 1 When is H, this is therefore a non-acidic proton in the context of the present invention.
[0099] In a preferred embodiment of the structures of the formulae (50) to (56), Z 1 , Z 2 and Z 3 At most one of the heteroatoms is O or NR 3 and the other groups are C(R 3 ) 2 Or C(R 1 ) 2 or Z 1 and Z 3 is the same or different at each occurrence and is O or NR 3 And Z 2 is C(R 1 ) 2 In a particularly preferred embodiment of the invention, Z 1 and Z 3 are the same or different for each occurrence, and C(R 3 ) 2 And Z 2 is C(R 1 ) 2 , more preferably C(R 3 ) 2 Or CH 2 It is.
[0100] Preferred forms of formula (50) are therefore structures of formulae (50-A), (50-B), (50-C) and (50-D), and particularly preferred forms of formula (50-A) are structures of formulae (50-E) and (50-F). [ka] Here, R 1 and R 3 has the meaning given above, and Z 1 , Z 2 and Z 3 is the same or different at each occurrence and is O or NR 3 It is.
[0101] Preferred embodiments of formula (51) are structures of the following formulae (51-A) to (51-F). [ka] Here, R 1 and R 3 has the meaning given above, and Z 1 , Z 2 and Z 3 is the same or different at each occurrence and is O or NR 3 It is.
[0102] Preferred embodiments of formula (52) are structures of the following formulae (52-A) to (52-E). [ka] Here, R 1 and R 3 has the meaning given above, and Z 1 , Z 2 and Z 3 is the same or different at each occurrence and is O or NR 3 It is.
[0103] In a preferred embodiment of the structure of formula (53), the bridgehead-linked radical R 1is H, D, F or CH 3 More preferably, Z 2 is C(R 1 ) 2 or O, more preferably C(R 3 ) 2 Preferred forms of formula (53) are therefore the structures of formulae (53-A) and (53-B), and a particularly preferred form of formula (53-A) is the structure of formula (53-C). [ka] The symbols used herein have the meanings given above.
[0104] In the preferred forms of the structures of formulae (54), (55) and (56), the radical R 1 is H, D, F or CH 3 More preferably, Z 2 is C(R 1 ) 2 Preferred forms of formulae (54), (55) and (56) are therefore structures of formulae (54-A), (55-A) and (56-A). [ka] The symbols used herein have the meanings given above.
[0105] More preferably, the G group in formulae (53), (53-A), (53-B), (53-C), (54), (54-A), (55), (55-A), (56) and (56-A) is selected from one or more R 2 a 1,2-ethylene group, optionally substituted with a radical, 2 is preferably identical or different at each occurrence and is H or an alkyl group having 1 to 4 carbon atoms, or has 6 to 10 carbon atoms and is one or more radicals R 2 ortho-arylene groups, in particular one or more radicals R 2
[0043] In one embodiment, the ortho-arylene group is an optionally substituted, but preferably unsubstituted, ortho-arylene group.
[0106] In a further preferred embodiment of the present invention, R in the groups of formulae (50) to (56) and in the preferred embodiments 3 are the same or different at each occurrence and are F, a linear alkyl group having 1 to 10 carbon atoms, or a branched or cyclic alkyl group having 3 to 20 carbon atoms, 2 The group is, in each case, R 2 C=CR 2 and one or more hydrogen atoms may be replaced by D or F), or having 5 to 14 aromatic ring atoms and, in each case, one or more radicals R 2 at the same time, two radicals R 3 may together form an aliphatic or aromatic ring system, thus forming a spiro system; furthermore, R 3 is the adjacent radical R or R 1 Together, they may form an aliphatic ring system.
[0107] In a particularly preferred embodiment of the present invention, R in the groups of formulae (50) to (56) and in the preferred embodiments 3 are identical or different at each occurrence and are F, a linear alkyl group having 1 to 3 carbon atoms, in particular methyl, or an aromatic ring atom having 5 to 12 and in each case one or more radicals R 2 at the same time, two radicals R 3 may together form an aliphatic or aromatic ring system, thus forming a spiro system; furthermore, R 3 is the adjacent radical R or R 1 Together, they may form an aliphatic ring system.
[0108] Particularly preferred examples of groups of formula (50) are the following groups: [ka] [ka]
[0109] Particularly preferred examples of groups of formula (51) are the following groups: [ka]
[0110] Particularly preferred examples of radicals of formula (52), (55) and (56) are the following radicals: [ka]
[0111] Particularly preferred radicals of formula (53) are the following radicals: [ka]
[0112] Particularly preferred examples of groups of formula (54) are the following groups: [ka]
[0113] When R radicals are attached to a divalent arylene or heteroarylene group of formula (4) in a bidentate ancillary ligand or ligand or in formula (2) or (3) or in the preferred forms thereof, these R radicals are the same or different at each occurrence and are preferably H, D, F, Br, I, N(R 1 ) 2 , OR 1 , CN, Si(R 1 ) 3 , B(OR 1 ) 2 , C(=O)R 1, a linear alkyl group having 1 to 10 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, or a branched or cyclic alkyl group having 3 to 10 carbon atoms, where the alkyl or alkenyl group is in each case also capable of containing one or more radicals R 1 or having 5 to 30 aromatic ring atoms and, in each case, one or more radicals R 1 and at the same time, the two radicals R together or R is selected from the group consisting of aromatic or heteroaromatic ring systems, optionally substituted by 1 and together with R may form a monocyclic or polycyclic, aliphatic or aromatic ring system. More preferably, these radicals R are identical or different at each occurrence and are preferably H, D, F, N(R 1 ) 2 , a linear alkyl group having 1 to 6 carbon atoms, or a branched or cyclic alkyl group having 3 to 10 carbon atoms, in which one or more hydrogen atoms may be replaced by D or F, or a group having 5 to 24 aromatic ring atoms, in particular 6 to 13 aromatic ring atoms, and in each case the radical R 1 and at the same time, two adjacent radicals R together or R is selected from the group consisting of aromatic or heteroaromatic ring systems, optionally substituted by 1 Together they may form a monocyclic or polycyclic, aliphatic or aromatic ring system.
[0114] Preferred R bonded to R 1 The radicals may be the same or different at each occurrence and are H, D, F, N(R 2 ) 2 , OR 2 , CN, a straight-chain alkyl group having 1 to 10 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, or a branched or cyclic alkyl group having 3 to 10 carbon atoms, where the alkyl group can in each case be represented by one or more radicals R 2 or having 5 to 24 aromatic ring atoms, and in each case, one or more R2 an aromatic or heteroaromatic ring system, optionally substituted by radicals; 1 The radicals together may form a monocyclic or polycyclic, aliphatic ring system. Particularly preferred are R 1 The radicals may be the same or different at each occurrence and may be H, F, CN, a linear alkyl group having 1 to 5 carbon atoms, or a branched or cyclic alkyl group having 3 to 5 carbon atoms, each of which may be represented by one or more radicals R 2 or having 5 to 13 aromatic ring atoms, in particular 6 to 13 aromatic ring atoms, and in each case one or more R 2 an aromatic or heteroaromatic ring system, optionally substituted by a radical; at the same time, two or more adjacent R 1 The radicals together may also form a mono- or polycyclic, aliphatic ring system.
[0115] Preferred R 2 The radicals, which may be identical or different at each occurrence, are H, F, or an aliphatic hydrocarbon radical having 1 to 5 carbon atoms, or an aromatic hydrocarbon radical having 6 to 12 carbon atoms; at the same time, two or more substituents R 2 may also together form a monocyclic or polycyclic, aliphatic ring system.
[0116] The preferred features described above can be combined with one another as desired, within the limits of claim 1. In a particularly preferred embodiment of the invention, the preferred features described above are applied simultaneously.
[0117] Examples of compounds of the present invention are those structures shown below. [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka]
[0118] The Ir-Pt complexes of the present invention are chiral structures. If the tripodal ligands of the complexes are also chiral, the formation of diastereomeric and multiple enantiomeric pairs is possible. In that case, the complexes of the present invention include both mixtures of different diastereomers or corresponding racemates and individual separated diastereomers or enantiomers.
[0119] Two identical ancillary ligands L 1 When a ligand having the formula: 1 -symmetric complex, i.e. a racemic mixture of Δ and Λ enantiomers, which may be separated by standard methods (chromatography on chiral materials / columns, or optical resolution by crystallization). [ka]
[0120] Optical resolution by fractional crystallization of diastereomeric salt pairs can be carried out by conventional methods. One option for this purpose is to react the uncharged Ir(III) complex with a fluorine atom (e.g., peroxide or H), as shown diagrammatically below.2 O 2 or by electrochemical means), adding an enantiomerically pure monoanionic base (chiral base) to the cationic Ir(IV) complex thus produced, separating the diastereomeric salts thus produced by fractional crystallization, and then reducing them with a reducing agent (e.g. zinc, hydrazine hydrate, ascorbic acid, etc.) to give the enantiomerically pure and uncharged complex. [ka]
[0121] Furthermore, enantiomerically pure or enantiomerically enriched synthesis is possible by complexation in chiral media (eg, R- or S-1,1-binaphthol).
[0122] When a ligand having three different ancillary ligands is used in the complex formation, what is typically obtained is a diastereomeric mixture of complexes, which can be separated by standard methods (chromatography, crystallization, etc.).
[0123] Enantiomerically pure C 1 -symmetric complexes can be selectively synthesized as shown in the following scheme. For this purpose, enantiomerically pure C 1 -symmetric ligands are prepared, complexed, the resulting diastereomeric mixtures are separated, and the chiral groups are separated. [ka]
[0124] Further functionalization to produce Ir-Pt complexes can be performed on the enantiomeric mixture or on each enantiomer. This does not change the stereochemistry on the iridium. If an additional stereocenter is introduced in this functionalization to produce an Ir-Pt complex, this results in diastereomers that can be separated by standard methods (chromatography, fractional crystallization, etc.).
[0125] The complexes of the invention can in particular be prepared by the route described hereinafter. For this purpose, first of all the central ancillary ligand, V 1 group and, when n=1 or 2, ancillary ligands L 1 A hexadentate ligand comprising: is then prepared, which is then used to prepare an iridium complex, which is functionalized on the central ancillary ligand para to the carbon atom coordinated to Ir, in particular by halogenation, preferably by bromination. In the coupling reaction, in the next step, L 2 -V 2 A group is introduced and, in a final step, the tetradentate ligand thus formed is coordinated to Pt.
[0126] Therefore, the present invention further provides a method for preparing the compounds of the present invention, characterized by the following steps: a)L 2 -V 2 Synthesis of hexadentate ligands not yet containing groups; b) Synthesis of Ir complexes from hexadentate ligands; c) functionalization of Ir complexes, in particular bromination; d) coupling reaction of said L 2 -V 2 introduction of groups; and e) Synthesis of Pt complexes
[0127] Suitable iridium reactants for the preparation of iridium complexes are especially iridium alkoxides of formula (57), iridium ketoketonates of formula (58), iridium halides of formula (59) or iridium carboxylates of formula (60). [ka] where R has the meaning given above, Hal is F, Cl, Br or I, and the iridium or rhodium reactants may be present in the form of the corresponding hydrates, where R is preferably an alkyl group having 1 to 4 carbon atoms.
[0128] Likewise, iridium compounds with both alkoxide and / or halide and / or hydroxyl and ketoketonate radicals can be used. These compounds may also be charged. Corresponding iridium compounds that are particularly suitable as reactants are disclosed in WO2004 / 085449. Particularly suitable are [IrCl 2 (acac) 2 ] - , e.g., Na[IrCl 2 (acac) 2 ], metal complexes with acetylacetonate derivatives as ligands, e.g., Ir(acac) 3 , or tris(2,2,6,6-tetramethylheptane-3,5-dionato)iridium, and IrCl 3 xH 2 O (where x is usually a number from 2 to 4).
[0129] The synthesis of the iridium complexes is preferably carried out as described in WO2002 / 060910 and WO2004 / 085449. In this case, the synthesis can also be activated, for example, by thermal or photochemical means and / or by microwave irradiation. Furthermore, the synthesis can also be carried out in an autoclave at high pressure and / or high temperature.
[0130] This reaction can be carried out in a melt of the corresponding ligand to be ortho-metallated without the addition of solvents or melting aids, which can be added if necessary. Suitable solvents are protic or aprotic solvents, for example aliphatic and / or aromatic alcohols (methanol, ethanol, isopropanol, t-butanol, etc.), oligo- and polyalcohols (ethylene glycol, propane-1,2-diol, glycerol, etc.), alcohol ethers (ethoxyethanol, diethylene glycol, triethylene glycol, polyethylene glycol, etc.), ethers (di- and triethylene glycol dimethyl ether, diphenyl ether, etc.), aromatic, heteroaromatic and / or aliphatic hydrocarbons (toluene, xylene, mesitylene, chlorobenzene, pyridine, lutidine, quinoline, isoquinoline, tridecane, hexadecane, etc.), amides (DMF, DMAC, etc.), lactams (NMP), sulfoxides (DMSO), sulfones (dimethyl sulfone, sulfolane, etc.), carboxylic acids (for example glacial acetic acid, propionic acid, fatty acids, benzoic acid) and water, as well as mixtures of these solvents. Suitable melting aids are compounds that are solid at room temperature but melt when the reaction mixture is heated and further dissolve the reactants to form a homogeneous melt. Particularly suitable are biphenyl, m-terphenyl, triphenyl, R- or S-binaphthol or the corresponding racemates, 1,2-, 1,3- or 1,4-bisphenoxybenzene, triphenylphosphine oxide, 18-crown-6, phenol, 1-naphthol, R-, S- or RS-1,1'-bisnaphthol, catechol, resorcinol, hydroquinone, etc. Particularly preferred here is the use of hydroquinone.
[0131] A suitable platinum reactant for the preparation of the platinum complex in the final synthesis step is, for example, PtCl 2 , Pt(ac) 2 , K 2 PtCl 4 , (DMSO) 2 PtCl 2 , (DMSO) 2PtMe 2 or (COD)PtCl 2 It is.
[0132] The synthesis of platinum complexes is preferably carried out in solution, suspension or melt. The same solvent / melting aid as in the preparation of iridium complexes can be used. The solvent used is preferably acetic acid or glacial acetic acid, and the melting aid is hydroquinone.
[0133] If necessary, the solubility of Pt complexes in salt form can be improved by adding salts such as lithium chloride, ammonium chloride, or tetraalkylammonium halides, or sulfates in catalytic, stoichiometric, or superstoichiometric amounts.
[0134] By these methods, optionally followed by purification, for example recrystallization or sublimation, the compound of the present invention of formula (1) can be obtained in high purity, preferably 99% ( 1 1 H-NMR and / or HPLC) can be used to obtain a purity greater than 1.0.
[0135] The compounds of the invention can also be rendered soluble by suitable substitution, for example by relatively long alkyl groups (about 4-20 carbon atoms), especially branched alkyl groups, or optionally substituted aryl groups, such as xylyl, mesityl, or branched, terphenyl or quaterphenyl groups. Another special method which brings about a clear improvement in the solubility of the metal complexes is to use condensed aliphatic groups, for example as shown by the formulae (50)-(56) disclosed above. Such compounds are, however, soluble in common solvents, for example toluene or xylene, at room temperature and in sufficient concentrations to allow processing of the complexes from solution. These soluble compounds are particularly suitable for processing from solution, for example by printing methods.
[0136] To process the metal complexes of the invention from the liquid phase, for example by spin-coating or printing methods, formulations of the metal complexes of the invention are required. These formulations may be, for example, solutions, dispersions or emulsions. For this purpose, it is preferable to use a mixture of two or more solvents. Suitable and preferred solvents are, for example, toluene, anisole, o-, m- or p-xylene, methyl benzoate, mesitylene, tetralin, veratrole, THF, methyl-THF, THP, chlorobenzene, dioxane, phenoxytoluene, in particular 3-phenoxytoluene, (-)-fenchone, 1,2,3,5-tetramethylbenzene, 1,2,4,5-tetramethylbenzene, 1-methylnaphthalene, 2-methylbenzothiazole, 2-phenoxyethanol, 2-pyrrolidinone, 3-methylanisole, 4-methylanisole, 3,4-dimethylanisole, 3,5-dimethylanisole, acetophenone, α-terpineol, benzothiazole, butyl benzoate, cumene, cyclohexanol, cyclohexanone, cyclohexylbenzene, decalin, dodecylbenzene, ethyl benzoate, indane, NMP, p-cymene, phene Examples of the solvent include but are not limited to, tallow, 1,4-diisopropylbenzene, dibenzyl ether, diethylene glycol butyl methyl ether, triethylene glycol butyl methyl ether, diethylene glycol dibutyl ether, triethylene glycol dimethyl ether, diethylene glycol monobutyl ether, tripropylene glycol dimethyl ether, tetraethylene glycol dimethyl ether, 2-isopropylnaphthalene, pentylbenzene, hexylbenzene, heptylbenzene, octylbenzene, 1,1-bis(3,4-dimethylphenyl)ethane, hexamethylindane, methylbiphenyl, 3-methylbiphenyl, 1-methylnaphthalene, 1-ethylnaphthalene, ethyl octanoate, diethyl sebacate, octyl octanoate, heptylbenzene, menthyl isovalerate, cyclohexyl hexanoate, or mixtures of these solvents.
[0137] The present invention therefore further provides a formulation comprising at least one compound of the present invention and at least one further compound.This further compound can be, for example, a solvent, in particular one of the above-mentioned solvents, or a mixture of these solvents.Alternatively, this further compound can be a further organic or inorganic compound, for example a matrix material, which is also used in electronic devices.This further compound can also be a polymer.
[0138] The compound of the present invention can be used as an active component, or as an oxygen sensitizer, or as a photocatalyst in electronic devices.The present invention therefore further provides the use of the compound of the present invention in electronic devices, or as an oxygen sensitizer, or as a photocatalyst.The present invention further provides an electronic device comprising at least one compound of the present invention.
[0139] An electronic device is understood to mean any device comprising an anode, a cathode and at least one layer, the layer comprising at least one organic or organometallic compound. Thus, an electronic device according to the invention comprises an anode, a cathode and at least one layer comprising at least one metal complex according to the invention. Preferred electronic devices are selected from the group consisting of organic electroluminescent devices (OLED, PLED), organic integrated circuits (O-IC), organic field effect transistors (O-FET), organic thin film transistors (O-TFT), organic light emitting transistors (O-LET), organic solar cells (O-SC) (understood to mean both purely organic solar cells and dye-sensitized solar cells (Grätzel cells)), organic photodetectors, organic photoreceptors, organic field quenching devices (O-FQD), light emitting electrochemical cells (LEC), oxygen sensors and organic laser diodes (O-laser), comprising at least one layer of at least one metal complex according to the invention. Particularly preferred are organic electroluminescent devices. The active component is generally an organic or inorganic material introduced between the anode and the cathode, for example, a charge injection, charge transport or charge blocking material, but particularly a light-emitting material and a matrix material.The compound according to the present invention shows particularly excellent properties as a light-emitting material in an organic electroluminescence device.Therefore, the preferred embodiment of the present invention is an organic electroluminescence device.Furthermore, the compound according to the present invention can be used for producing singlet oxygen or for photocatalysis.
[0140] An organic electroluminescent device comprises a cathode, an anode and at least one light-emitting layer. Apart from these layers, it can contain further layers, for example in each case one or more of a hole injection layer, a hole transport layer, a hole blocking layer, an electron transport layer, an electron injection layer, an exciton blocking layer, an electron blocking layer, a charge generating layer and / or an organic or inorganic p / n-junction. At the same time, one or more hole transport layers can be formed from, for example, MoO 3 Or WO 3The organic electroluminescent device may be p-doped with metal oxides such as fluorinated fluorine, or with (per)fluorinated electron-deficient aromatic systems, and / or one or more electron transport layers may be n-doped. Similarly, intermediate layers may be introduced between two emitting layers, which may have the function of, for example, blocking excitons and / or controlling the charge balance in the organic electroluminescent device. However, it is pointed out that none of these layers necessarily need to be present.
[0141] In this case, the organic electroluminescent element may contain one light-emitting layer or may contain several light-emitting layers. If several light-emitting layers are present, they preferably have several emission maxima over the entire 380 nm to 750 nm range, resulting in an overall white emission, i.e. various light-emitting compounds that can fluoresce or phosphoresce are used in the light-emitting layers. Particularly preferred are three-layer systems in which three layers exhibit blue, green and orange or red emission, or systems with more than three light-emitting layers. Also preferred are tandem OLEDs. The systems may be hybrid systems in which one or more layers fluoresce and one or more other layers phosphoresce. White-emitting organic electroluminescent elements can be used for lighting applications or, together with color filters, for full-color displays.
[0142] Infrared iris sensors are also based on the principle of organic electroluminescent elements described above, where the organic electroluminescent elements in this application emit light in the infrared region of the spectrum. The characteristic light reflected by the eye is detected by the camera.
[0143] In a preferred embodiment of the invention, the organic electroluminescent device comprises a metal complex according to the invention as emissive compound in one or more light-emitting layers, in particular in a red or infrared-emitting layer.
[0144] When the metal complex of the invention is used as a luminescent compound in the luminescent layer, it is preferably used in combination with one or more matrix materials. The mixture of the metal complex of the invention and the matrix material comprises, based on the total mixture of the luminescent material and the matrix material, 0.1 to 99% by weight, preferably 1 to 90% by weight, more preferably 3 to 40% by weight, and in particular 5 to 25% by weight of the metal complex of the invention. Correspondingly, the mixture comprises, based on the total mixture of the luminescent material and the matrix material, 99.9 to 1% by weight, preferably 99 to 10% by weight, more preferably 97 to 60% by weight, and in particular 95 to 75% by weight of the matrix material.
[0145] The matrix material used is generally any material known in the art for that purpose. It is preferred that the triplet level of the matrix material is higher than the triplet level of the emitter.
[0146] Suitable matrix materials for the compounds of the invention are ketones, phosphine oxides, sulfoxides and sulfones (for example according to WO2004 / 013080, WO2004 / 093207, WO2006 / 005627 or WO2010 / 006680), triarylamines, carbazole derivatives (for example CBP (N,N-biscarbazolylbiphenyl), m-CBP, or other compounds described in WO2005 / 039246, US2005 / 0069729, JP2004 / 288381, carbazole derivatives disclosed in EP 1205527, WO 2008 / 086851 or US 2009 / 0134784), biscarbazole derivatives, indolocarbazole derivatives (for example according to WO 2007 / 063754 or WO 2008 / 056746), indenocarbazole derivatives (for example according to WO 2010 / 136109 or WO 2011 / 000455), azacarbazole derivatives (for example according to EP 1617710, EP 1617711, EP 17 31584, JP 2005 / 347160), bipolar matrix materials (for example, according to WO 2007 / 137725), silanes (for example, according to WO 2005 / 111172), azaboroles or boronic acid esters (for example, according to WO 2006 / 117052), diazasilol derivatives (for example, according to WO 2010 / 054729), diazaphosphole derivatives (for example, according to WO 2010 / 054730), triazine derivatives (for example, according to WO 2010 / 0 15306, WO2007 / 063754 or WO2008 / 056746), zinc complexes (for example according to EP652273 or WO2009 / 062578), dibenzofuran derivatives (for example according to WO2009 / 148015 or WO2015 / 169412), or bridged carbazole derivatives (for example according to US2009 / 0136779, WO2010 / 050778, WO2011 / 042107 or WO2011 / 088877).
[0147] It is preferred to use a mixture of several different matrix materials, in particular a mixture of at least one electron-conducting matrix material and at least one hole-conducting matrix material. A preferred combination is, for example, the use of aromatic ketones, triazine derivatives or phosphine oxides together with triarylamine derivatives or carbazole derivatives, in particular biscarbazole derivatives, as a mixed matrix for the compounds according to the invention. Preference is also given to the use of a mixture of a charge-transporting matrix material, as described, for example, in WO2010 / 108579, and an electrically inactive matrix material that does not, if at all, play a significant role in the charge transport. Preference is also given to the use of two electron-transporting matrix materials, as described, for example, in WO2014 / 094964, for example, a triazine derivative and a lactam derivative.
[0148] Listed below are examples of compounds suitable as matrix materials for the compounds according to the present invention.
[0149] Examples of triazines and pyrimidines that can be used as electron transport matrix materials are the following compounds: [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka]
[0150] Examples of lactams that can be used as electron transport matrix materials are the following compounds: [ka] [ka] [ka] [ka] [ka] [ka]
[0151] Examples of indolo- or indeno-carbazole derivatives in the broadest sense which, depending on the substitution pattern, can be used as hole- or electron-transporting matrix materials are the following compounds: [ka] [ka] [ka] [ka]
[0152] Examples of carbazole derivatives which, depending on the substitution pattern, can be used as hole- or electron-transporting matrix materials are the following compounds: [ka] [ka]
[0153] Examples of bridged carbazole derivatives which can be used as hole-transporting matrix materials are the following compounds: [ka] [ka] [ka] [ka]
[0154] Examples of biscarbazoles which can be used as hole-transporting matrix materials are the following compounds: [ka] [ka] [ka] [ka]
[0155] Examples of amines which can be used as hole-transporting matrix materials are the following compounds: [ka] [ka] [ka]
[0156] Examples of materials that can be used as wide band gap matrix materials are the following compounds: [ka]
[0157] It is further preferred to use a mixture of two or more triplet emitters with a matrix. In this case, the triplet emitter with a shorter wavelength emission spectrum serves as a co-matrix for the triplet emitter with a longer wavelength emission spectrum. For example, the shorter wavelength emitting metal complex can be used as a co-matrix for the metal complex of the present invention that emits longer wavelengths. In this case, it is also preferred when both the shorter wavelength- and longer wavelength-emitting metal complexes are compounds of the present invention. Suitable co-matrix materials are also in particular the compounds disclosed in WO2016 / 124304 and WO2017 / 032439.
[0158] Examples of suitable triplet emitters that can be used as co-dopants for the compounds of the present invention are shown in the table below. [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka]
[0159] Preferred cathodes are metals, metal alloys or multilayer structures of various metals with a low work function, such as alkaline earth metals, alkali metals, metals of the main group or lanthanides (e.g. Ca, Ba, Mg, Al, In, Mg, Yb, Sm, etc.). Furthermore, suitable are alloys of alkali metals or alkaline earth metals with silver (e.g. alloys of magnesium and silver). In the case of multilayer structures, in addition to the metals, further metals with a relatively high work function (e.g. Ag) can also be used, in which case metal combinations such as Mg / Ag, Ca / Ag or Ba / Ag are commonly used. It is also possible to introduce thin intermediate layers, preferably made of materials with a high dielectric constant, between the metal cathode and the organic semiconductor. Examples of materials useful for this purpose are the fluorides of alkali metals or alkaline earth metals, as well as the corresponding oxides or carbonates (e.g. LiF, Li 2 O, BaF 2 , MgO, NaF, CsF, Cs 2 CO 3 Also useful for this purpose are organic alkali metal complexes, such as Liq (lithium quinolinate). The layer thickness of this layer is preferably 0.5 to 5 nm.
[0160] Preferred anodes are materials with a high work function. Preferably, the anode has a work function greater than 4.5 eV against vacuum. Firstly, metals with high redox potential are suitable for this purpose, for example Ag, Pt or Au. Secondly, it may also be preferably a metal / metal oxide electrode (for example Al / Ni / NiOx, Al / PtOx). In some applications, at least one electrode needs to be transparent or partially transparent to allow either the irradiation of the organic material (O-SC) or the emission of light (OLED / PLED, O-LASER). Here, preferred anode materials are conductive mixed metal oxides. Particularly preferred are indium tin oxide (ITO) or indium zinc oxide (IZO). Preferred are further conductive doped organic materials, in particular conductive doped polymers, for example PEDOT, PANI or derivatives of these polymers. Further preferred is when a p-doped hole transport material is applied to the anode as a hole injection layer, in which case suitable p-dopants are, for example, MoO 3 Or WO 3 or (per)fluorinated electron-deficient aromatic systems. Further suitable p-dopants are HAT-CN (hexacyanohexaazatriphenylene) or the compound NPD9 from Novaled. Such layers facilitate hole injection into materials with a low HOMO, i.e. a HOMO that is large in strength.
[0161] In the further layers it is generally possible to use any of the materials used according to the prior art for these layers, and the skilled person can combine any of these materials with the materials of the invention in an electronic device without any inventive effort.
[0162] Since the service life of such components is significantly shortened in the presence of water and / or air, the components are structured accordingly (depending on the application), provided with contacts and finally hermetically sealed.
[0163] Further preferred is an organic electroluminescent device characterized in that one or more layers are applied by sublimation. In this case, the materials are usually -5 Less than mbar, preferably less than 10 -6 It is applied by vacuum deposition in a vacuum sublimation system at an initial pressure of less than 10 mbar. The initial pressure can be lower or higher, e.g. -7 It is also possible to go below mbar.
[0164] Likewise preferred are organic electroluminescent devices characterized in that one or more layers are applied by the OVPD (organic vapor phase deposition) method or by sublimation using a carrier gas. -5 The material is applied at pressures between mbar and 1 bar. A special case of this method is the OVJP (Organic Vapor Jet Printing) method, in which the material is applied directly by a nozzle and thus structured.
[0165] Further preferred are organic electroluminescent devices characterized in that one or more layers are prepared from solution, for example by spin-coating or by printing techniques (for example screen printing, flexographic printing, offset printing or nozzle printing), more preferably by LITI (Light Induced Thermal Imaging, Thermal Transfer Printing) or inkjet printing. In a preferred embodiment of the invention, the layer comprising the compound of the invention is applied from solution.
[0166] Organic electroluminescent devices can also be produced as hybrid systems, by coating one or more layers from solution and one or more further layers by vacuum deposition, for example an emissive layer comprising a metal complex according to the invention and a matrix material can be coated from solution and thereto a hole blocking layer and / or an electron transporting layer can be coated by vacuum deposition under reduced pressure.
[0167] These methods are generally known to those skilled in the art and can be easily applied by those skilled in the art to organic electroluminescent devices comprising compounds of formula (1) or the preferred forms detailed above.
[0168] The electronic devices, and particularly the organic electroluminescent devices, of the present invention are notable for one or more of the following surprising advantages over the prior art. 1. The compounds of the present invention are capable of deep red and infrared emission. 2. The compounds of the present invention have very high photoluminescence quantum yields in the infrared region, leading to excellent efficiency when used in infrared-emitting organic electroluminescent devices. 3. The compounds of the present invention have a very short luminescence lifetime, which when used in organic electroluminescent devices leads to improved roll-off characteristics and also leads to higher luminescence quantum yields due to the avoidance of non-radiative relaxation channels. 4. The compounds of the present invention, especially those with n=1, exhibit polarized emission and therefore have high efficiency.
[0169] The present invention is explained in more detail by the following examples, which are not intended to limit the present invention, and those skilled in the art can use the details described to manufacture further electronic devices according to the present invention without inventive effort, and thus practice the present invention throughout the scope of the claims.
[0170] Working Example: The following syntheses are carried out in dry solvents under a protective gas atmosphere unless otherwise stated. Metal complexes are furthermore handled in the dark or under yellow light. Solvents and reagents can be purchased, for example, from Sigma-ALDRICH or ABCR. Each number in brackets or the number given for the individual compounds refers to the CAS number of the literature-known compound. In the case of compounds that can have multiple tautomeric forms, one tautomeric form is represented. Ir complexes are typically obtained as Δ and Λ enantiomeric mixtures.
[0171] A: Synthesis of synthon S: Example S1: [ka] Preparation similar to Example 21 of WO2016 / 124304 (see page 116). Reactants: 24.8 g (100 mmol) of 5-bromo-2-(3-methylphenyl)pyridine [1215073-45-2]. Yield: 22.2 g (75 mmol); 75% of theory; Purity: 98%. 1 By H NMR.
[0172] Example S50: [ka] Preparation similar to Example 200 of WO2016 / 124304 (see page 140). Reactants: 28.2 g (100 mmol) of 2-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine [1319255-85-0]. Yield: 22.2 g (75 mmol); 75% of theory; Purity: 98%. 1 By H NMR.
[0173] In a similar manner, the following compounds can be prepared: [ka]
[0174] Example S100: [ka] Preparation similar to example 5 of WO2017 / 032439 (see page 93). Reactants: 68.1 g (210 mmol) of S52. Yield: 42.5 g (71 mmol); 71% of theory; Purity: 98% 1 By H NMR.
[0175] In a similar manner, the following compounds can be prepared: [ka]
[0176] Example S150: [ka] To a mixture of 59.9 g (100 mmol) of S100, 26.7 g (105 mmol) of bis(pinacolato)diborane, 29.4 g (300 mmol) of potassium acetate (anhydrous), 50 g of glass beads (diameter 3 mm) and 500 ml of THF, 821 mg (2 mmol) of SPhos and 225 mg (1 mmol) of palladium(II) acetate are added with good stirring, and the mixture is heated under reflux for 24 hours. After cooling, the salt and glass beads are suction filtered through a bed of Celite in the form of a THF slurry, which is washed with a small amount of THF, and the filtrate is concentrated to dryness. The residue is taken up in 150 ml of MeOH, stirred in warm solvent, and the crystallized product is suction filtered, washed twice with 30 ml of methanol each and dried under reduced pressure. Yield: 56.0 g (81 mmol); 81% of theory; Purity: approx. 95% 1 By H NMR.
[0177] In a similar manner, the following compounds can be prepared: [ka]
[0178] B: Synthesis of Ir ligand L: Example L1 [ka] To a mixture of 69.1 g (100 mmol) of S150, 31.1 g (100 mmol) of S50, 63.7 g (300 mmol) of tripotassium phosphate, 400 ml of toluene, 200 ml of dioxane and 400 ml of water, 1.64 g (4 mmol) of SPhos and then 449 mg (2 mmol) of palladium(II) acetate are added with good stirring and the mixture is heated under reflux for 24 hours. After cooling, the organic phase is removed, washed twice with 300 ml each of water and once with 300 ml of saturated sodium chloride solution and dried over magnesium sulfate. The desiccant is filtered through a bed of Celite in the form of a toluene slurry, the filtrate is concentrated to dryness under reduced pressure and the glassy crude product is recrystallized from acetonitrile / ethyl acetate at boiling. Yield: 56.5 g (71 mmol); 71% of theory; Purity: about 95% 1 By H NMR.
[0179] In a similar manner, the following compounds can be prepared: [ka]
[0180] Synthesis of C:Ir complexes and their bromination Example: Ir(L1) [ka] A mixture of 7.95 g (10 mmol) of l-ligand L1, 4.90 g (10 mmol) of trisacetylacetonatoiridium(III) [15635-87-7] and 120 g of hydroquinone [123-31-9] is initially charged into a 1000 ml two-neck round-bottom flask equipped with a glass-coated magnetic core. The flask is equipped with a water separator (for media less dense than water) and an argon-blanketed air condenser. The flask is placed on a metal heat bath. The apparatus is purged with argon for 15 minutes from above with an argon-blanketed system, allowing argon to flow through the side of the two-neck flask. Through the side of the two-neck flask, a glass-coated Pt-100 thermocouple is introduced into the flask, with its end located just above the magnetic stir bar. The apparatus is then insulated by several loose rolls of household aluminum foil, the insulation reaching the center of the riser tube of the water separator. The apparatus is then rapidly heated to 250-255 °C (measured by a Pt-100 thermal sensor attached to the molten stirred reaction mixture) using a laboratory hotplate stirrer. For another 2 hours, the reaction mixture is kept at 250-255 °C, during which a small amount of condensate is distilled off and collected in a water separator. After 2 hours, the mixture is cooled to 190 °C, the heating mantle is removed, and 100 ml of ethylene glycol is added dropwise. After cooling to 100 °C, 400 ml of methanol are slowly added dropwise. The yellow-orange suspension thus obtained is filtered through a double-headed frit, the yellow solid is washed three times with 50 ml of methanol and dried under reduced pressure. Crude yield: quantitative. The solid thus obtained is dissolved in about 200 ml of dichloromethane and, in the dark and with the exclusion of air (it remains dark initially), filtered in the form of a dichloromethane slurry through about 1 kg of silica gel (column diameter about 18 cm). The core fraction is removed and concentrated on a rotary evaporator while MeOH is continuously added dropwise until it crystallizes.After suction filtration, washing with a little MeOH, and drying under reduced pressure, the orange product is further purified by three hot extractions with dichloromethane:i-propanol (1:1, v / v) and two hot extractions with dichloromethane / acetonitrile (in each case initially loaded with about 200 ml, extraction thimble: standard Soxhlet thimble made of Whatman cellulose) in succession, with careful exclusion of air and light. Mother liquor losses can be adjusted with the ratio of dichloromethane (low boiling point and good solubility): isopropanol or acetonitrile (high boiling point and poor solubility). Typically, it should be 3-6 wt% of the amount used. Hot extraction can also be achieved with other solvents such as toluene, xylene, ethyl acetate, butyl acetate, etc. Finally, the product is p~10. -6 Heat treatment under high vacuum at 1000 mbar and T~350~400 °C. Yield: 7.48 g (7.6 mmol), 76%; Purity: about 99.8% by HPLC.
[0181] In a similar manner, the following compounds can be prepared: [ka]
[0182] Example: Ir(L1-Br) [ka] To a well-stirred suspension of 9.84 g (10 mmol) Ir(L1) in 500 ml DCM, 1.78 g (10.5 mmol) N-bromosuccinimide is added in one portion at room temperature in the dark, and the mixture is stirred for another 16 h. After removing about 450 ml DCM under reduced pressure, 100 ml methanol and 0.3 ml hydrazine hydrate are added to the yellow-green suspension, and the yellow solid is suction filtered, washed three times with about 50 ml methanol, and dried under reduced pressure. Yield: 9.78 g (9.2 mmol); 92% of theory; purity: >99.0% by NMR.
[0183] In a similar manner, the following compounds can be prepared: [ka]
[0184] D: Synthesis of Ir complexes with Pt ligands Example: Ir(L1A) [ka] A mixture of 10.66 g (10 mmol) of Ir(L1-Br), 3.43 g (20 mmol) of 3-(2-pyridinyl)phenol [98061-22-4], 5.53 g (40 mmol) of potassium carbonate, 930 mg (1 mmol) of triphenylphosphine-copper(I) bromide [15709-74-7], 50 g of glass beads, 70 ml of DMF and 90 ml of o-xylene is heated on a water separator until further water is separated (about 18 hours). The reaction mixture is cooled to 70 ° C, suction filtered through a Celite bed in the form of an o-xylene slurry, and the filtrate is concentrated to dryness. The residue is hot extracted with 150 ml of MeOH, and the solid is suction filtered, rinsed with 20 ml of MeOH each and dried. The solid is taken up in about 200 ml of dichloromethane (DCM):ethyl acetate (EA) (9:1 vv) and filtered through a silica gel column (8 cm diameter, 30 cm length) in the form of a slurry, and the orange core fraction is removed. The dichloromethane is rotary evaporated under normal pressure, continuously replacing the evaporated volume with methanol, and the product crystallizes. The orange product is suction filtered, washed twice with 20 ml of methanol each time and dried under reduced pressure. Yield: 8.85 g (7.6 mmol); 76% of theory; purity: >99.0% by NMR.
[0185] In a similar manner, the following compounds can be prepared: [ka] [ka] [ka] [ka]
[0186] Example: Ir(L1F) [ka] A well-stirred mixture of 10.66 g (10 mmol) of Ir(L1-Br), 4.92 g (20 mmol) of N-phenyl-3-(2-pyridinyl)phenylamine [1325592-74-2], 1.94 g (20 mmol) of sodium tert-butoxide, 202 mg (1 mmol) of tri-tert-butylphosphine, 157 mg (0.7 mmol) of palladium(II) acetate and 150 ml of o-xylene is heated under reflux for 18 hours. The reaction mixture is cooled to 70° C., suction filtered through a bed of celite in the form of an o-xylene slurry, and the filtrate is concentrated to dryness. The solid is taken up in about 200 ml of dichloromethane (DCM):ethyl acetate (EA) (9:1 vv) and filtered through a silica gel column (8 cm diameter, 30 cm length) in the form of a DCM:EA (9:1 vv) slurry to remove the orange core fraction. The dichloromethane is rotary evaporated under standard pressure, continuously replacing the evaporated volume with methanol, and the product crystallizes. The orange product is suction filtered, washed twice with 20 ml of methanol each time and dried under reduced pressure. Yield: 8.37 g (6.8 mmol); 68% of theory; purity: >99.0% by NMR.
[0187] In a similar manner, the following compounds can be prepared: [ka]
[0188] E: Synthesis of Ir-Pt complex Example IrPt(L1A) [ka] A mixture of 11.56 g (10 mmol) of Ir(L1A), 4.15 g (10 mmol) of potassium tetrachloroplatinate [10025-99-7], 3.4 g (80 mmol) of lithium chloride, anhydrous, 50 g of glass beads and 100 ml of glacial acetic acid is stirred well at 80° C. for 70 hours. After cooling to about 50° C., 100 ml of water is added dropwise and the precipitated crude product is suction filtered, washed three times with 30 ml of a mixture of methanol:water (1:1 vv) and three times with 30 ml each of ethanol and dried under reduced pressure. The solid is taken up in about 200 ml of DCM in the dark and filtered through a silica gel bed (diameter 8 cm, length 30 cm) in the form of a DCM slurry and the deep red core fraction is removed. DCM is distilled off on a rotary evaporator under reduced pressure, continuously replacing the distilled volume with methanol, and the product crystallizes. The product is suction filtered, washed twice with 20 ml of methanol each, and dried under reduced pressure. The product is further purified by four successive hot extractions with dichloromethane:isopropanol (1:1, vv) and four hot extractions with dichloromethane / acetonitrile (in each case about 200 ml of initial charge, extraction thimble: standard Soxhlet thimble made of Whatman cellulose) continuously, with careful exclusion of air and light. Mother liquor losses can be adjusted with the ratio of dichloromethane (low boiling point and good solubility):isopropanol or acetonitrile (high boiling point and poor solubility). Typically, it should be 3-6 wt% of the amount used. Hot extraction can also be achieved with other solvents such as toluene, xylene, ethyl acetate, butyl acetate, etc. Finally, the product is obtained at p~10 -6 Heat treated under high vacuum at 1000 mbar and T ~ 370 ~ 450 °C. Yield: 7.16 g (5.3 mmol); 53% of theory; Purity: > 99.8% by NMR.
[0189] In a similar manner, the following compounds can be prepared: [ka] [ka] [ka] [ka] [ka] [ka]
[0190] Example: OLED manufacturing 1) Vacuum processed elements The OLEDs according to the invention and according to the prior art are produced by the general methods according to WO2004 / 058911, which are adapted to the circumstances described therein (variations in layer thicknesses, materials used).
[0191] In the following examples, various OLED results are shown. Cleaned coated glass plates are used (Miele laboratory glass washer, Extran detergent from Merck), coated with 50 nm structured ITO (indium tin oxide) and pretreated with UV ozone for 25 min (PR-100 UV ozone generator from UVP), which are coated within 30 min with 20 nm PEDOT:PSS (poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate), purchased as CLEVIOS® P VP AI 4083 from Heraeus Precious Metals GmbH, Germany, spin-coated from an aqueous solution) for process improvement, and baked at 180° C. for 10 min. These coated glass plates form the substrates on which the OLEDs are applied. The OLED basically has the following layer structure: substrate / Hole Injection Layer 1 (HIL1) made of HTM1 doped with 5% NDP-9 (available from Novaled), 20 nm / / Hole Transport Layer 1 (HTL1) made of HTM1, 150 nm / Hole Transport Layer 2 (HTL2) / Emitting Layer (EML) / Hole Blocking Layer (HBL) / Electron Transport Layer (ETL) / Optional Electron Injection Layer (EIL), and finally the cathode. The cathode is formed by a 100 nm thick layer of aluminum.
[0192] First, vacuum processed OLEDs are described. For this purpose, all materials are applied by thermal evaporation in a vacuum chamber. In this case, the emitting layer always consists of at least one matrix material (host material) and a light-emitting dopant (emitter) mixed in a certain volume ratio into the matrix material by co-evaporation. A specification given in the form M1:M2:IrPt(L) (55%:35%:10%) means here that the material M1 is present in the layer in a volume ratio of 55%, M2 in a volume ratio of 35% and IrPt(L) in a volume ratio of 10%. Similarly, the electron transport layer may consist of a mixture of two materials. The exact structure of the OLED is given in Table 1. The materials used in the manufacture of the OLED are given in Table 4.
[0193] OLEDs are characterized by standard methods. For this purpose, the electroluminescence spectrum, the current efficiency (measured in cd / A) and power efficiency (measured in lm / W) and the external quantum efficiency (EQE, measured in percent) (as a function of luminance, determined from the current-voltage-luminance characteristic (IUL characteristic) assuming a Lambertian emission characteristic), and the lifetime are determined. The electroluminescence spectrum is determined for 1000 cd / m 2 It is measured in terms of brightness.
[0194] Use of the compounds of the present invention as emitter materials in phosphorescent OLEDs One use of the compounds of the present invention is as phosphorescent emitting materials in the emissive layer of an OLED. The materials used are shown in Table 4. The results of a non-fully optimized OLED are summarized in Table 2. [Table 1] [Table 2] *Dark after adaptation
[0195] Solution Processed Devices A: Low molecular weight, soluble functional materials The iridium complexes of the invention can also be processed from solution, which is significantly simpler in process technology compared to vacuum-processed OLEDs, but leads to OLEDs with good properties. The production of such components is based on the production of polymer light-emitting diodes (PLEDs), which have already been described many times in the literature (for example WO 2004 / 037887). The structure is composed of: substrate / ITO / hole injection layer (130 nm) / interlayer (20 nm) / emissive layer (60 nm) / hole blocking layer (10 nm) / electron transport layer (50 nm) / cathode. For this purpose, a substrate (soda-lime glass) from Technoprint is used, which is provided with an ITO structure (indium tin oxide, transparent conductive anode). The substrate is cleaned in a clean room with deionized water and a cleaning agent (Deconex 15PF) and then activated by UV / ozone plasma treatment. Then, also in a clean room, a 20 nm hole injection layer is applied by spin coating. The required spin speed depends on the degree of dilution and on the concrete spin coater geometry. To remove residual moisture from the layer, the substrate is baked on a hotplate at 200 ° C for 30 min. The intermediate layer used plays the role of hole transport, in this case HL-X from Merck is used. Alternatively, this intermediate layer can be replaced by one or more layers which simply have to fulfill the condition that they are not desorbed again by the subsequent process steps of depositing the EML from the solution. For the production of the emissive layer, the triplet emitter of the invention is dissolved in toluene or chlorobenzene together with a matrix material. The typical solids content of such a solution is 16-25 g / l for such devices, where by spin coating the device obtains a typical layer thickness of 60 nm. Solution processed Type 1 devices contain an emissive layer composed of M1:M3:M4:IrPtL (20%:30%:30%:20%) and Type 2 contains an emissive layer composed of M3:M4:Ir-Red:IrPtL (30%:34%:28%:8%). The emissive layer is spun on in an inert gas atmosphere, in this case argon, and baked at 160° C. for 10 minutes.A hole blocking layer (10 nm ETM1) and an electron transport layer (50 nm ETM1 (50%) / ETM2 (50%)) are deposited thereon (evaporation apparatus such as Lesker, typical deposition pressure: 5×10). -6 mbar). Finally, a cathode of aluminum (100 nm) (high purity metal from Aldrich) is applied by evaporation. To protect it from air and atmospheric moisture, the device is finally encapsulated and then characterized. The OLED examples given are not yet optimized. Table 3 summarizes the data obtained. [Table 3] *Dark after adaptation [Table 4-1] [Table 4-2]
Claims
1. A compound of the following formula (1a-3), (1b-3), (1c-3), (1d-3), (1e-3) or (1f-3): 【Chemistry 1】 (wherein the R' radicals ortho to the coordination to the metal are the same or different in each occurrence and are H, D, F, CH 3 and C.D. 3 The symbols and subscripts used are as follows: L 1 and L 2 is the same or different at each occurrence and is a bidentate ancillary ligand selected from the structures of formulae (L-1) and (L-2), 【Chemistry 2】 (wherein the dotted bond represents the ancillary ligand L 1 V 1 or a secondary ligand L 2 V 2 and other symbols are as follows: CyC is the same or different at each occurrence, is an aryl or heteroaryl group having 6-13 aromatic ring atoms, substituted or unsubstituted by R, and is coordinated to Ir or Pt via a carbon atom and bonded to CyD via a covalent bond; CyD is the same or different at each occurrence, is a heteroaryl group having 6-10 aromatic ring atoms, substituted or unsubstituted by R, and is coordinated to Ir or Pt via a nitrogen atom or via a carbene carbon atom and is bonded to CyC via a covalent bond; At the same time, two adjacent substituents R may together form a ring system which is monocyclic or polycyclic and aliphatic, heteroaliphatic, aromatic or heteroaromatic; V 1 is a central ancillary ligand that is a partial structure enclosed in [ ] of formula (1a-3), (1b-3), (1c-3), (1d-3), (1e-3) or (1f-3), depending on the selection of n, and is connected to each other and to L 1 is a trivalent group bonded to V 1 is selected from the groups of formula (5') and (9') 【Chemistry 3】 (wherein the dotted bond indicates a bond to a central ancillary ligand, which is a substructure enclosed in [ ] of formula (1a-3), (1b-3), (1c-3), (1d-3), (1e-3) or (1f-3), or to an ancillary ligand L 1 Other symbols that are used indicate bonds to: A is the same or different for each occurrence - CR 2 -CR 2 - or a group of formula (14) 【Chemistry 4】 (where the dotted bond indicates a bond to the central subligand or to the subligand L 1 to this structure, and * indicates the position of the bond to the central ring group of the unit of formula (14), i.e., the benzene ring group shown in formula (5') or the cyclohexane group in (9'); V 2 represents a central ancillary ligand and L which are partial structures surrounded by [ ] of formula (1a-3), (1b-3), (1c-3), (1d-3), (1e-3) or (1f-3). 2 is a divalent group that bonds 2 But, CR 2 ,NR,O,S,Se,-CR 2 -CR 2 -, -CR 2 -O-, -CR=CR-, or an ortho-linked arylene or heteroarylene group having 5 or 6 aromatic ring atoms and optionally substituted by one or more R radicals; n is 1, 2 or 3; m is the same or different at each occurrence and is 0 or 1, with the proviso that at least one m is 1; R is identical or different at each occurrence and is selected from the group consisting of H, D, F, CN, a linear alkyl group having 1 to 6 carbon atoms or a branched or cyclic alkyl group having 3 to 10 carbon atoms, in which one or more hydrogen atoms may be replaced by D or F, or an aromatic ring atom having 6 to 13, and in each case one or more R 1 at the same time, two adjacent R radicals together may form a ring system which is monocyclic or polycyclic and aliphatic, heteroaliphatic, aromatic or heteroaromatic; R 1 are identical or different at each occurrence and are H, D, F, CN, a linear alkyl group having 1 to 5 carbon atoms or a branched or cyclic alkyl group having 3 to 5 carbon atoms, said alkyl group being in each case represented by one or more R 2 radicals), or 6 to 13 aromatic ring atoms, in each case one or more R 2 an aromatic or heteroaromatic ring system, optionally substituted by a radical; and at the same time, two adjacent R 1 the radicals together may form a ring system which is monocyclic or polycyclic, and aliphatic, heteroaliphatic, aromatic or heteroaromatic; R 2 is the same or different at each occurrence and is H, D, F or an aliphatic hydrocarbyl radical having 1 to 5 carbon atoms, or an aromatic hydrocarbyl radical having 6 to 12 carbon atoms (wherein one or more hydrogen atoms may be replaced by F).
2. V 1 The compound according to claim 1, characterized in that is selected from the structure of the following formula (5a″): 【Chemistry 5】 (wherein R and the dotted bond have the meanings given in claim 1).
3. One or more ancillary ligands L 1 and L 2 are identical or different at each occurrence, and have a structure of the following formula (L-1-1), (L-1-2), (L-2-1), (L-2-2) or (L-2-3): 【Chemistry 6】 (where * indicates the position of coordination to Ir or Pt, and "o" indicates that the structure is L 1 When the form is: 1 indicates the position of the bond to the 2 When the form is: 2 is bonded in the ortho position relative to the coordination to Pt; 1 Or V 2 The symbol X to which is attached is C, X being identical or different on each occurrence and CR, R having the meaning given in claim 1.
4. A method for the preparation of a compound selected from the group consisting of IrPt(L1A), IrPt(L1B), IrPt(L1C), IrPt(L1D), IrPt(L1E), IrPt(L2A), IrPt(L3A), IrPt(L4A), IrPt(L1F), IrPt(L1G), IrPt(L1H), and IrPr(L4B), characterized in that the method comprises the process steps of: a) the following compound: 【Chemistry 7】 with 1-bromo-2-iodobenzene to produce the following compound (S-50), (S-51), (S-52), (S-53) or (S-54); 【Chemistry 8】 Furthermore, (S-52), (S-53), (S-54), or the following formula: 【Chemistry 9】 The compound (I) is reacted with 2,2-(5-chloro-1,3-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaboronate), further with bis(pinacolato)diborane, and further with compound (S-50) or (S-51) to obtain the following compound (L1), (L2), (L3) or (L4): 【Chemistry 10】 By generating L 2 -V 2 synthesizing a hexadentate ligand that does not contain a group; b) synthesizing from said hexadentate ligand from step a) an Ir complex of the formula Ir(L1), Ir(L2), Ir(L3) or Ir(L4): 【Chemistry 11】 ; c) brominating said Ir complex by reaction with N-bromosuccinimide to produce the following compounds Ir(L1-Br), Ir(L2-Br), (L3-Br) or Ir(L4-Br): 【Chemistry 12】 ; d) coupling each of the Ir complexes with the reactants shown in the table below to obtain the L defined in the formula of claim 1; 2 -V 2 introducing a group to obtain the corresponding product as shown in the table below: 【Table 1】 【Table 2】 【Table 3】 【Table 4】 【Table 5】 【Table 6】 and e) using the product from d) as a reactant as shown in the table below and reacting the reactant with potassium tetrachloroplatinum to synthesize the corresponding product Ir-Pt complex as shown in the table below: 【Table 7】 【Table 8】 【Table 9】 【Table 10】 【Table 11】 【Table 12】 。
5. A formulation comprising at least one compound according to any one of claims 1 to 3 and at least one further solvent or matrix material.
6. Use of a compound according to any one of claims 1 to 3 in an electronic device or as an oxygen sensitizer or as a photocatalyst.
7. An electronic device comprising at least one compound according to any one of claims 1 to 3.
8. 8. The electronic device according to claim 7, which is an organic electroluminescent device, characterized in that the compound is used as a light-emitting compound in one or more light-emitting layers.
Citation Information
Patent Citations
Polydentate dinuclear cyclometalated complexes containing N^C^C^N-N^C^C^N-type ligands
CN107698623A
Metal coordination compound and organic luminescent element
JP2003073388A
Material for organic electroluminescent element, organic electroluminescent element, display device and illumination device
JP2006298999A
JPP6999655B
Iridium / platinum metal complex
US20150069334A1
